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ABSTRACT 
The Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor, 
which mediates the potent toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) and related compounds. AhR is regulated by the ligand-binding domain 
(LBD) of the AhR, and so determining how the binding of ligand activates AhR is 
of considerable interest. However, there are no structural data on mammalian AhR 
LBDs, and expression of the mouse AhR LBD in E. coli yields insoluble protein. 
Expression in more complex systems, such as insect cells (Spodoptera frugiperda), 
yields soluble AhR LBD, but only ~10% of the total protein is in a ligand-binding 
competent form. 
In order to address the structure of the AhR LBD, we have used a model system. 
There is good amino acid sequence similarity between human AhR and C. elegans 
AhR (CeAhR). We have investigated whether the three dimensional structure of 
CeAhR LBD will help in understanding this structure in mammals. 
CeAhR LBD was cloned into the vector pRSET to give histidine-tagged protein. 
The clones were then transformed into E. coli BL21(DE3) or Arctic Express 
strains, followed by induction with IPTG. Bacteria were lysed and 100000g 
supernatants were prepared. Proteins were purified by Ni2+ affinity 
chromatography. 
Expression of recombinant proteins in the bacterial system revealed that the 
induced protein from the pRSET.CeAhR LBD construct was ~29 kDa, as 
predicted. Large amounts of these proteins were produced (~5-10% of total 
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bacterial protein) and the vast majority was insoluble. However, on preparation of 
a 100000g supernatant, the samples yielded small amounts of soluble CeAhR LBD 
fusion protein. This is in contrast to results obtained with mouse AhR LBD, which 
yielded no detectable protein in a 100000g supernatant. The CeAhR LBD proteins 
were successfully purified by affinity chromatography and were obtained in good 
yield from the original cytosols. However, the yield of soluble AhR fusion protein 
was ~100 microgrammes of protein per litre of BL21(DE3) bacterial culture. The 
experiment was repeated using Arctic Express bacteria, which have a 
constitutively expressed chaperonin, and express at 12°C. However, the yield of 
protein was similar, at ~100 microgrammes of protein per litre.  
Thus the CeAhR LBD yields soluble protein in a bacterial expression system, but 
the levels of expression are too low to enable this protein to be purified for use in 
structural studies. Trials to express CeAhR LBD in transgenic C. elegans and 
Pichia pastoris yielded no soluble protein.  
The research moved to look for ligands for CeAhR by using a lethality test with C. 
elegans in vivo studies. The results showed that TCDD and AZ1c (from 
AstraZeneca) affect the wild type C. elegans, but without killing them. Repeating 
this test on AhR null animals showed that the effects were abolished. Thus the 
CeAhR is a receptor that appears to bind TCDD and AZ1c, albeit weakly, contrary 
to previous reports in the literature. 
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1 INTRODUCTION 
1.1 2,3,7,8-tetrachlorodibenzo-p-dioxin and its toxic effects 
 2,3,7,8-tetrachlorodibenzo-p-dioxin (Collier et al., 2008) (Figure 1) is a known 
toxin that induces a wide range of toxic effects including hepatic toxicity, 
teratogenic disorders, and reproductive and carcinogenic effects (Pocar et al., 
2005; Schwarz and Appel 2005) TCDD is also responsible for neurological and 
immunological manifestations (Dzeletovic et al., 1997). TCDD is often referred to 
as simply “dioxin”, although, strictly speaking dioxin is only a part of this 
molecule (Figure 1). It is considered one of the most toxic planar halogenated 
hydrocarbons, and is a waste product of industrial processing of organic 
compounds containing halogens. Another major source is chlorine bleaching of 
paper pulp. Burning wood produces TCDD and related dioxins that are stable in 
the ecosystem (Lohmann et al., 2006; Pandelova et al., 2009). These compounds 
accumulate in the food chain in the fatty compartments of fish, birds and mammals 
and dioxin particles can stick to the top of plants (Clarkson 1995; Pohl et al., 1995; 
Loonen et al., 1996; Meulenbelt and de Vries 2005; Kamphues and Schulz 2006). 
They are lipophilic compounds that stay in the body for many years. The half life 
of TCDD in humans is at least 7 years (Birnbaum 1994). There are 75 different 
compounds, which are considered to be polychlorinated dibenzo-p-dioxin family 
members. These compounds differ in the number and location of the chlorine 
atoms (Figure 1). The most dangerous structures are the tetra-chlorinated ones, 
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because they are very difficult to metabolise, and this is why it has a very long half 
life in the body (Leung et al., 2006). 
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Figure 1. The chemical structures of p-dioxin, dibenzo-p-dioxin with the ring numbering 
system and TCDD.  
 
The toxicity of TCDD became the focus of attention since the early 1970s, when 
2,4,5-trichlorophenoxyacetic acid (2,4,5-T) derivatives were used as herbicides in 
the USA and Vietnam. During the war in Vietnam, Agent Orange, a 1:1 mixture of 
the n-butyl esters of 2,4-dichlorophenoxyaceticacid (2,4-D) and 2,4,5-T, was 
sprayed over a wide area as a chemical weapon (Kramarova et al., 1998; Schecter 
et al., 1998; LaKind and Filser 1999). The toxic effects were detected in pregnant 
mothers and the biological manifestations were confirmed in rodents. The 
teratogenic effect of 2,4,5-T was due to the presence of TCDD as part of the 
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mixture. For 40 years, research has been ongoing on dioxin and its molecular 
mechanisms. The toxic effects of dioxin depend on many factors, including the 
dose, the route, the species, and the age and sex of the animal. For example, guinea 
pigs are very sensitive while the hamster is relatively resistant. The half-life of 
dioxin in rodents is just weeks, in comparison to years in humans due to the fatty 
component inside the body. The toxic effects range from nausea, vomiting, 
headache, chloracne, psychological problems and various cancers. TCDD is a 
well-known non-genotoxic carcinogen (Dencker 1985; Cole et al., 2003; Abalos et 
al., 2010). It is also said that dioxin promotes cancer progression in humans and 
animals. Experimental chronic exposure to TCDD induces chronic wasting 
syndrome and is responsible for the atrophy of the lymphoid tissue, including the 
thymus. TCDD also has immunotoxic effects, as it affects the maturation of T 
cells, reduces cell proliferation and reduces cytokine secretions, and this is claimed 
to reduce the anti-tumour immunity. TCDD contamination is responsible for 
hepatoxicity, thyroid dysfunctions and the development of Diabetes Mellitus 
(Pearce and Braverman 2009; Chang et al., 2010). It affects gonadal maturation in 
males and induces placental dysfunction (Dencker 1985; Cole et al., 2003; Abalos 
et al., 2010) and miscarriage in females (Sharara et al., 1998). TCDD induces skin 
lesions and carcinogenic effects (Lin et al., 2003). Acute TCDD toxicity induces 
wasting and weight loss in experimental animals. TCDD suppressed the 
expression of genes that affect lipid and glucose metabolism, like Hmgcr, Fasn, 
Srebf1 which are involved in diabetes (Sato et al., 2008). 
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1.2 AhR identification 
TCDD promotes its toxic effects through activation of a protein receptor known as 
the aryl hydrocarbon receptor (Hankinson 1995; Ko et al., 1996; Sato et al., 2008). 
It has been shown that intracellular calcium control interacts with the regulation of 
target genes affected by AhR stimulation (Monteiro et al., 2008).  
AhR is responsible for regulation of multiple genes, which leads to immunologic, 
hepatic and skin toxicity. It is noteworthy that transgenic mice over-expressing 
AhR develop spontaneous cancer (Tauchi et al., 2005). Related research showed 
that down-regulation of the aryl hydrocarbon receptor repressor (AhRR) was 
responsible for increased incidence of cancer in colon, breast, lung, stomach and 
cervix. AhR and AhRR work in a feedback loop to regulate each other. AhR 
activation stimulates the expression of AhRR, and at the same time AhRR down 
regulates the expression of AhR (Zudaire et al., 2008). Thus, the implication is that 
a decrease in AhRR leads to carcinogenesis through greater constitutive activity of 
AhR. 
AhR may contribute to physiological functions, for example, cell proliferation, 
differentiation, motility and migration (Kleman et al., 1994; Seidel et al., 2000). 
The creation of AhR-knockout mice enabled a focus on the role of AhR in normal 
growth. The results showed that AhR null mice exhibit reduced liver weight and 
portal fibrosis (Schmidt et al., 1996). Recent research work showed that AhR null 
mice express high levels of TGF-ȕ DQG 7*)-ȕ IDFWRUV 7UDQVIRUPLQJ *URZWK
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Factor Beta) that are expected to induce liver fibrosis and liver cell apoptosis 
(Chang et al., 2007). So it is proposed that AhR has triple functional activity. The 
first function is the adaptive metabolic response to PAH (Polycyclic Aromatic 
Hydrocarbons), the second effect is the toxic response to TCDD and the third is 
the developmental role in liver and vascular growth. The former two effects are 
mediated by known ligands, but the last one is not clear. In order to understand 
how AhR regulates liver growth and vascular development, experiments have been 
performed to create a hypomorphic allele of the AhR locus and dioxin was given 
to the growing embryo. The results showed that dioxin protected the growing mice 
from the liver and the vascular malformations seen in AhR hypomorphic mice. 
This experiment suggests that an endogenous ligand may be required for normal 
AhR function (Walisser et al., 2005).    
Differences in the susceptibility to dioxins in the same species and even the same 
strain raised the question of the genetic polymorphism before the AhR was 
discovered. PAH induced CYP1A1 (final target of AhR stimulation) in mice liver. 
Crossing and back crossing of multiple inbred mice strains resulted in the 
identification of the AhR genetic locus that is responsible for induction of 
CYP1A1 before the discovery of AhR receptor protein. Adverse mutation of that 
locus blocks the response of CYP1A1 to PAH related compounds. A soluble 
cytosolic receptor model for AhR was suggested to promote aryl hydrocarbon 
responses. Studies discovered 2 complexes, one about 6S and the other was about 
9S in the rat liver extract. They bind radioactive TCDD but no signal was detected 
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from the extracts taken from mutated AhR locus (DBA/N2) mice. Furthermore, 
these complexes are protein in nature as they were affected by proteases but not 
affected by DNAse or RNAse. Competitive displacement of TCDD was achieved 
by other CYP1A1 inducers. Neither Phenobarbital (CYP inducer) nor steroid 
hormones managed to displace radioactive TCDD. A new step towards 
identification of AhR was the discovery of 2-azido-3-iodo-7,8-dibromodibenzo-ɪ-
dioxin. This is a photo activatable ligand that binds covalently with the proposed 
AhR on exposure to ultraviolet light. This ligand helped in discovering 2 protein 
masses in Hepa-1 cells of 70 kDa and 95 kDa, although the first protein was just 
an artefact proteolytic fragment (Beischlag et al., 2008). In 1988, Perdew and 
Poland successfully purified AhR partially and later on antibodies against AhR 
were developed (Bradfield and Poland 1988). Co immune-precipitation of AhR 
resulted in discovery of Hsp90 as a chaperone protein. Primers of the human AhR 
locus were constructed and the AhR was cloned from human genomic DNA for 
further extensive characterisation in the 1990s by Oliver Hankinson (Hankinson 
1995).  This revealed proteins in the molecular weight range from 95 to 105 kDa 
and containing approximately 805 amino acids. 
 
1.3 AhR structural domains 
The AhR has four main structural domains (Figure 2): 1- basic helix-loop-helix 
(bHLH) domain; 2- PAS-A domain; 3- PAS-B domain; 4- glutamine-rich domain. 
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Figure 2. Diagram of the various domains of the mouse AhR adapted from (Fukunaga et al., 
1995) . 
 
Studies were carried out to analyse the two PAS (PER: circadian clock protein, 
ARNT: aryl hydrocarbon receptor nuclear translocator protein, SIM: single minded 
protein) domains of AhR. The PAS-A domain is involved in the interaction 
between AhR and other proteins. Removal of PAS A causes weak dimerisation 
with ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) and stops 
transcription. Removal of PAS-B produces an AhR that is capable of binding 
ARNT, but not activating ligands. AhR PAS B is supposed to bind ligands and 
chaperones, including Hsp90 (Heat Shock Protein), p23 (co-chaperone of the AhR 
complex) and AIP (Aryl hydrocarbon receptor Interacting Protein) (Denison et al., 
2002). The pocket that acquires ligands, i.e. the Ligand Binding Domain (LBD), is 
included partially in the PAS B domain (Figure 2) (McIntosh et al., 2010). 
Therefore, in AhR the PAS B domain has wider interactions than PAS A. The 
bHLH is mainly related to binding DNA and Hsp90. The transactivation domain is 
dedicated to binding the dioxin response element (DRE), the binding site on DNA 
that promotes gene expression. The DRE has conservative DNA structure in 
various species (Sun et al., 2004). 
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1.4 PAS domain proteins 
PAS domain proteins are a group of conservative 3-dimensional structure proteins, 
despite their heterogeneous primary structure. They are widespread in the animal 
kingdom from bacteria to humans. All these proteins contain alpha helices and 
beta sheets. The protein structure contains a HLH (helix-loop-helix) motif at the N 
terminal site followed by the PAS domain (Card et al., 2005; Pandini and Bonati 
2005; Imamoto and Kataoka 2007). Experimental studies cut the HLH domain, 
and the PAS domain is still able to fold properly in the case of the PAS domain of 
PYP (photo active yellow) protein. This result is very important, as it is claimed 
that the AhR LBD could fold properly without expressing the full length AhR. 
Computer simulation studies propose that the PAS domain proteins have a 
common 3-dimensional structure. Furthermore, the simulations are optimistic in 
that they indicate that these proteins bind ligands in the same way (Chapman-
Smith et al., 2004). The discovery of the crystal structure of any member of these 
proteins would be a major step forward, allowing us to know more about the 
structure of the whole group, that is to say one PAS domain protein is a good 
template for other members of the group. The first member of these protein 
domains was discovered in the Drosophila clock protein, PER (Period Protein). 
The second was the ARNT protein. The majority of PAS domain proteins work as 
environmental sensors (Figure 4), for example, PYP, FixL (The Oxygen Sensor 
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Protein), HERG (potassium channel protein), LOV (Light Oxygen Voltage 
protein), ARNT and AhR (Vreede et al., 2003).  
PAS
Steroids
Neurological
Development
VoltageLight
Food
Oxygen
Toxicants
 
Figure 3. Diagram representing the functions of PAS domain proteins as environmental 
sensors (McIntosh et al., 2010). PAS domain proteins can act as light sensors like PYP, oxygen 
and energy sensors, voltage sensors of a potassium channel , neuronal regulators like C. 
elegans AhR, toxin metabolism like mammalian AhR and as part of a steroid receptor. 
 
Currently, 34 mammalian proteins are considered to be PAS proteins. Furthermore, 
thousands of PAS proteins were discovered in many other species ranging from 
bacteria and plants to humans. The discovery of this huge number of proteins was 
attributed to the use of expanding data in the Genebank. 
Mammalian PAS domain proteins play an important role in the hypoxia response 
pathway. During periods of low oxygen, the hypoxia inducing factor (HIF alpha) is 
released to help anaerobic respiration, angiogenesis and an increase in red blood 
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cell production. At normal levels, oxygen helps proteolysis of the normally 
produced HIF. With increase in hypoxia, the degradation of HIF decreases with net 
result of increased PAS domain containing HIF. The protein moves to the nucleus 
and binds ARNT, similar to AhR, and finally stimulates DNA to produce different 
enzymes needed for the target function (Kamae et al., 2010; Pasanen et al., 2010; 
Wenger and Hoogewijs 2010). 
The second important PAS domain function is the dioxin response pathway. The 
ligand binds to the PAS domain protein, AhR, where it translocates to the nucleus 
and binds to ARNT, and then the complex binds the DNA response element (see 
section 1.7 for more detail). It is a similar transduction pathway to that of HIF 
alpha. 
The third function of mammalian PAS domain proteins is maintenance of the 
circadian rhythm of the animal. Most organisms have the ability to adapt with the 
diurnal changes of light and darkness. These changes are called the circadian 
rhythm. In humans, the sleep wake cycle is regulated by endogenous biological 
clocks that exist in every organ. However, the master biological clock rests on the 
optic chiasm as part of the supra-chiasmatic nucleus. These biological clocks 
control the different biological changes between day and night. For example, the 
diurnal changes in blood pressure, the immune function and pituitary secretion are 
changed according to the function of the biological clock (Qu et al., 2010). Many 
genes are regulated by the circadian rhythm, including the PAS domain repressor 
proteins. These proteins are translated and phosphorylated, then they translocate to 
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the nucleus and bind to ARNT. The complex interacts with the DNA response 
element expressing a battery of genes that promote sleep, metabolism and other 
physiological changes (Hennig et al., 2009; McIntosh et al., 2010). 
 
 
Figure 4. Different PAS domain structural models: HIF-Į$517 G3(5 +(5* K3$6.
Phy3, NCoA, FixL and PYP. Secondary structure has been predicted by the Kabsch and 
Sander method.  Both FixL and PYP models were created according to their X-ray structures 
(Pandini et al., 2007). 
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1.5 Endogenous AhR agonists 
Some researchers have hypothesised that AhR is a receptor without a specific 
ligand, but there are several endogenous AhR agonists including bilirubin, 
biliverdin, metabolites of tryptophan, indirubin, indigo and other compounds. 
Typically, these compounds can activate AhR, but with less potency than TCDD. 
The functions of these, and other endogenous AhR ligands is unclear (Petersen et 
al., 2006). There are two theories; the first is that AhR has a physiological ligand 
that, as yet, is unidentified. It is supposed that the ligand, factor or hormone 
modulates the physiological AhR function, especially during embryonal 
development. AhR mutated mice change their phenotype without any xenobiotic 
exposure, supporting the theory that AhR has a physiological function. The battery 
of genes stimulated by the AhR-ARNT complex also indicates that AhR has a 
physiological function. The other theory claims that AhR is an orphan receptor that 
has an adaptive environmental function. It is thought that AhR detoxifies 
endogenous products during development. AhR can bind multiple endogenous 
compounds with different structure. This makes understanding the mechanism of 
ligand receptor binding interesting. These different endogenous chemicals are 
claimed to be waste products that are harmful to both embryo and adults. A third 
theory exists that is a mix of both mentioned models suggesting that AhR has dual 
function; one function is xenobiotic metabolism and the other function is 
supporting embryonic maturation and normal physiology.  
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The big classes of AhR agonists include the halogenated aromatic hydrocarbons, 
the family of polychlorinated biphenyls and the polycyclic aromatic hydrocarbons. 
On the other hand, there are various endogenous groups of chemicals, for example, 
indigoids, arachidonic acid metabolites and heme metabolites.  
Indigoids are weak endogenous AhR ligands. Indirubin is supposed to be the most 
potent indigoid in binding AhR but is 100 times less potent than TCDD 
(Prochazkova et al., 2010). Some studies consider indigoids as AhR agonists, 
others consider them as partial agonists. These chemicals can be found in human 
urine below nanomolar level. The antagonistic effects of indigoids on 
transformation have been studied. In mouse hepatoma, expression of CYP1A1 is 
reduced in Hepa-1c1c7 cells loaded with indigoids, and indirubin in particular. The 
translocation of AhR into the nucleus was inhibited. On administering 10mg/kg 
body weight/day orally to mice for three consecutive days, the CYP1A1 
expression in liver did not increase for indigoids (Nishiumi et al., 2008). Quinone 
reductase induction was recorded on supplementation with indirubin and indigo. 
These experiments concluded that indigoids are considered as antagonists of the 
AhR receptor, especially for low amounts in mice (Nishiumi et al., 2008). 
1.5.1 Equilinin (3-hydroxy-1,3,5(10),6,8-estrapentaen-17-one) 
This weak endogenous ligand works as an AhR agonist. It is known to induce 
CYP1A1 and is considered an oestrogen derivative. It is used in hormonal 
replacement therapy for post-menopausal women (Bhavnani and Woolever 1981; 
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Orstan et al., 1986). In common with other AhR ligands, it has a planar structure 
that differs from other oestrogens (Jinno et al., 2006). 
1.5.2 (1’H-indole-3’-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) 
ITE is an AhR agonist capable of stimulating the DNA response element. 
Gestational exposure of ITE did not show teratogenic manifestation. Some studies 
claim that ITE is a physiological ligand of AhR, however, there is no evidence that 
ITE is present in humans. ITE is known to be a potent murine AhR agonist. 
Experimental studies carried out on lung fibroblasts showed that ITE induces a 
wide variety of genes, similar to TCDD, but without manifest cytotoxicity. The 
difference between TCDD and ITE is attributed to the short half life of ITE in 
comparison to the persistent TCDD (Henry et al., 2010). 
1.5.3 Arachidonic acid metabolites  
Studies showed that there is a link between AhR transduction and prostaglandin 
synthesis. Lipoxin A4, an arachidonic acid metabolite, is suggested to selectively 
bind AhR. Lipoxin A4 both stimulates AhR (Schaldach et al., 1999; Sanchez et al., 
2010) and inhibits (SOCS)-2 (suppressor of cytokine signalling 2) transduction, 
which is considered an anti-inflammatory action (Machado et al., 2006). This 
compound is an interesting focus of research, because its structure is unique. It 
was found to differ widely from TCDD in chemical structure and ligand binding, 
in structure studies performed to measure the mRNA of CYP1A1 on adding 
lipoxin A4 to Hepa-1 cells. The results concluded that Lipoxin A4 stimulated the 
AhR complex and induced CYP1A1 (Schaldach et al., 1999). 
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1.5.4 Heme metabolites  
 Heme metabolites are considered AhR agonists. Experimental studies on diseased 
rats with jaundice manifestation showed induction of CYP1A1. Heme, biliverdin 
and bilirubin, the most potent, are supposed to bind AhR (Sinal and Bend 1997; 
Phelan et al., 1998) and induce translocation to the nucleus, where the DNA 
response element is activated, inducing a battery of genes, including the mRNA of 
CYP1A1. In vitro experiments were carried out on the effect of hemin, biliverdin, 
and bilirubin on expression of CYP1A1 in Hepa-1c1c7 cells (Sinal and Bend 
1997). A dose-response curve showed an increase in CYP1A1 induction by all 
three chemicals. The positive results appeared after 1 hour with biliverdin or 
bilirubin, however, the increase in CYP1A1 mRNA took more than 2 hours with 
hemin. Hepa-1c1c7 cells supplemented with these compounds induced a dose-
response curve of CYP1A1-dependent 7-ethoxyresorufin-O-deethylase (EROD) 
activity with the best response generated by bilirubin (Sinal and Bend 1997). 
1.5.5 Tryptophan metabolites  
Tryptophan metabolites can bind AhR and promote transformation of the AhR 
complex. Furthermore, tryptophan and its metabolites induce CYP1A1 in rat liver 
cells. AhR is considered part of the protective metabolising system that protects 
from toxic metabolites, like tryptophan, that could be produced in excess by the 
normal microflora or due to contamination from the external enivironment 
(Schrenk et al., 1999). 
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1.5.6 Dietary compounds  
Some dietary compounds can act as AhR agonists. Candidates include Indole-3-
carbinol derivatives and natural flavinoids. The first group of compound can be 
found in vegetables like broccoli, and the second, especially plant polyphenols, 
can be found in fruits and vegetables (de Waard et al., 2008; Nguyen and Bradfield 
2008). 
 
1.6 Polycyclic aromatic hydrocarbons (PAHs) 
Animal studies showed that exposure to some polycyclic aromatic hydrocarbons 
(PAHs) induced breast cancer, which is partly due to stimulation of AhR-mediated 
transcription, thereby inducing CYP family members that oxidise PAHs into 
carcinogenic intermediates (Trombino et al., 2000). Adding coal tar to rabbit’s ear 
induces pre-cancerous papillomas that transform to cancer; this was recorded in 
the 1930s. PAHs were the active carcinogenic substances that exist in the coal tar 
(Filatova et al., 1973; Bickers and Kappas 1978; Lycheva et al., 1990; Liu et al., 
2009). The PAHs are metabolised by CYP1A1 into more toxic intermediates that 
induce DNA damage (Mahadevan et al., 2007). On the other hand, PAHs are, like 
TCDD, AhR agonists that transform AhR into the nucleus and stimulate the DNA 
response element to produce a battery of proteins and enzymes, but less potently. 
At the same time, PAHs induce active metabolites that induce the CYP1A family 
and metabolise PAHs themselves in a cycle that takes from 12-24 hours. Studies 
carried out on human lymphocytes showed that cells treated with PAHs in vitro 
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were transformed into malignant lymphoplasts (Saurabh et al., 2010). Other 
studies looked at the relationship between PAHs and bronchogenic carcinoma. 
These effects were demonstrated in cigarette smoking, which is related to cancer 
of the lung, larynx and oral cavity. Cigarette smoke contains hundreds of 
chemicals, including PAHs (Nebert et al., 1993; Nebert et al., 2000; Nebert et al., 
2004). In addition, burning organic material is an important source of PAHs; yet, 
the major source is oil spills. Unfortunately, these compounds are lipophilic and 
stay in the ecosystem for a long time. PAHs are also produced during cooking; for 
example, vegetables cooked multiple times at high temperature develop a group of 
carcinogenic compounds, including PAHs (Srivastava et al., 2010; Srivastava et 
al., 2010).  
 
1.7 AhR signalling pathway 
The AhR-receptor contains a basic helix-loop-helix (bHLH) DNA binding domain 
(Abel and Haarmann-Stemmann 2010) and two PAS domains, which are a 
sequence motif related to that in the Drosophila circadian rhythm regulatory 
protein, period (Dzeletovic et al., 1997). Once TCDD combines with AhR, it 
undergoes conformational changes and the AhR/chaperone complex translocates to 
the nucleus (Figure 6). The AhR then dissociates from its chaperone proteins 
(Hsp90, AIP, and p23) and following the association with another protein, ARNT, 
it binds to DNA and induces transcription (Figure 6). ARNT also belongs to the 
bHLH-PAS family (Mary et al., 2005). One of the chaperone proteins is Hsp90, 
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which dissociates from the TCDD/AhR complex after translocation to the nucleus. 
Inside the nucleus, the AhR-ligand-ARNT complex binds to a specific DNA motif 
called the dioxin response element (DRE) (Dzeletovic et al., 1997; Stevens et al., 
2009). 
AhR stimulates transcription of many genes encoding different metabolising 
enzymes, like the cytochrome P450 family, e.g. CYP1A1, glutathione transferase, 
UDP-glucuronyl transferase, NADPH and quinone oxidoreductase (Tang et al., 
2008). 
 
Figure 5. Diagram of the AhR pathway following binding with ligands like dioxin (Stevens et 
al., 2009). DRE is Dioxin Response Element. ARA9 is another name for the chaperone AIP. 
Hsp90 is heat shock protein. ARNT is the aryl hydrocarbon receptor nuclear translocator 
protein. 
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1.8 Composition of AhR complex and chaperones 
Non-liganded AhR is found in the cytosol complexed with chaperone proteins 
including two Hsp90 molecules (a heat shock protein of 90 kDa weight), AIP (also 
known as ARA9 and XAP2) and p23.  
Hsp90 keeps the receptor stable in the cytoplasm and prevents it from going to the 
nucleus. The function of p23 is not fully understood, but it is thought to support 
the interaction between AhR and Hsp90 (Stevens et al., 2009). AIP is supposed to 
help proper folding and signalling of AhR. On binding of the ligand, the AhR 
complex moves to enter the nucleus and Hsp90 and the other chaperones 
dissociate from the complex leaving ARNT to bind AhR prior to signalling 
(Stevens et al., 2009). Hsp90 is a tetrameric chaperone protein that maintains AhR 
in its proper configuration. Hsp90 is known to stabilise other receptors like the 
glucocorticoid receptor. Cancer cells produce Hsp90 in huge amounts to induce 
metastasis and thus are a target of anti-cancer research to arrest metastasis. Hsp90 
is formed of 3 domains, where the N domain is the amino terminal domain, and 
the M domain is the middle domain that binds the AhR or other interacting protein, 
while the C domain is the carboxyl terminal domain that is a target for drugs or co-
chaperones (Dao-Phan et al., 1997; Trepel et al., 2010). On the other hand, C. 
elegans’ Hsp90 has a different function and does not stabilise or bind AhR 
(Powell-Coffman et al., 1998). Mammalian Hsp90 binds to AhR at two different 
sites, and by binding to the AhR complex it keeps its configuration in a state that is 
stable in the cytoplasm. Studies have been carried out to analyse the function of 
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Hsp90 in relation to AhR. Experimental loading with geliandamycin that inhibits 
Hsp90 binding resulted in decreased AhR in the cytoplasm, because of the 
increased degradation. This experiment indicates the essential role of Hsp90 in 
maintaining the AhR complex in the cytoplasm (Bell and Poland 2000). Once 
ligand binds to AhR, it is subjected to subsequent change in topology and 
translocates to the nucleus where it dissociates from the binding chaperones. A 
process called transformation ends in the expression of a battery of genes 
producing different AhR effects (Kazlauskas et al., 2001; Petrulis and Perdew 
2002). 
A study by was carried out where a conditional mouse model was created (Nukaya 
et al., 2010). The AIP locus of the model mouse hepatocytes was deleted to study 
the mechanisms of AIP in AhR signalling. The study discovered two functions of 
the 330 amino acid AIP protein in AhR transduction. (i) The normal AIP induction 
in hepatocytes is important to keep cytosolic AhR protein in a stable state in the 
mammalian liver. (ii) Expression of the AIP chaperone is important for ligand 
receptor complex transformation, and promoting the hepatic toxicity of dioxins. 
The genes expressed by AhR are affected by AIP expression in heterogenous 
response. The genes of CYP1B1 and AhRR are AIP-dependent for dioxin-induced 
toxicity, while both CYP1A1 and CYP1A2 are not AIP dependent. These results 
indicate that the mammalian AhR-responsive elements are more than one group 
that would need more extensive research to understand the genes responsible for 
the toxic effects of dioxin on the liver (Nukaya et al., 2010). AIP has multiple 
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interactions, and AhR is one factor that binds AIP. On the other hand, AIP interacts 
with phosphodiesterase-4a5, a protein, which is essential for the function of cAMP. 
Deregulation of phosphodiestrerase inhibitor and down-regulation of cAMP is 
responsible for isolated familial pituitary adenoma, which is inherited in an 
autosomal dominant pattern due to germline mutation of the area encoding for AIP. 
The AIP protein inhibits degradation of AhR, prolonging its half life in the 
cytoplasm. The AhR-AIP interaction keeps the configuration of the AhR complex 
away from interacting with other transcription factors in the absence of the AhR 
ligands (Leontiou et al., 2008; Pesatori et al., 2008). 
P23 is a co-chaperone protein, which is a member of the receptor complex group. 
It is part of the AhR chaperone complex that binds the N-terminal of Hsp90 
chaperone. Before ligand binding to AhR, the complex chaperones protect the 
receptor from transformation. Without p23, it is thought that it is difficult for 
Hsp90 to dissociate from the AhR receptor before it binds ARNT. Also, the ligand 
affinity of AhR decreases without the help of p23. P23 has functions other than as 
part of the AhR receptor complex. It binds Hsp90 as a co-chaperone for steroid 
receptors, which is important in ligand affinity to the glucocorticoid receptor. 
Other functions include prevention of protein aggregation and playing a role in 
telomerase activity. Knock-down p23 is lethal to animals because of the defective 
lung function due to dysfunction of the steroid receptor that is essential for lung 
maturation in utero (Kazlauskas et al., 1999; Flaveny et al., 2009). 
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1.9 AhR and carcinogenesis 
AhR was discovered by Poland and his group more than 30 years ago (Poland et 
al., 1976). It mediates most or all effects of dioxin and related compounds (Poland 
et al., 1976; Brauze et al., 2006). These chemicals are considered carcinogenic, 
where AhR creates a model for cancer mechanisms, and has intrinsic effects on the 
cell cycle without binding exogenous ligands. It inhibits the cell cycle progression 
and induces cell cycle arrest, which contradicts its role in cancer precipitation 
(Gramatzki et al., 2009; Ma et al., 2009; Barhoover et al., 2010). On exposure to 
TCDD, a full agonist of human AhR, the ligand receptor complex transforms and 
translocates into the nucleus resulting in expression of a battery of genes that play 
DUROHLQSKDVHȱDQGSKDVHȱȱPHWDEROLVP0DQ\WUDQVFULSWLRQDOIDFWRUVDUHLQGXFed 
either directly or secondarily and these modulate the cell cycle. TCDD results in 
an increase in tyrosine kinase (Blankenship and Matsumura 1997; Backlund and 
Ingelman-Sundberg 2005) and stimulates the MAP kinase pathway. These proto-
oncogenes are involved in human hepatoma (Yim et al., 2004; Borlak and Jenke 
2008). AhR induces the c-myc gene that is related to breast cancer (Yang et al., 
2005; Jensen et al., 2006). The outcome of studies was that AhR induces FOS and 
JUN families that are considered oncogenes, which may participate in cancer 
development. The constitutively active CA-AhR-transgenic in, for example, 
B6C3F1-mice, showed development of stomach cancer and liver tumours, despite 
a decrease in body weight and increased apoptosis. This model may explain how 
AhR induces cancer and inhibits the cell cycle at the same time (Moennikes et al., 
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2004; Marlowe and Puga 2005). AhR is involved in cancer through two 
mechanisms depending on the class of AhR agonists. The first group is HAHs 
(Halogenated Aromatic Hydrocarbons), which include TCCD. These are 
considered non-genotoxic carcinogens, producing cancer without genotoxicity. In 
inducing cancer, the mechanism involves 3 stages; the first is intiation, the second 
is promotion, and the third is progression. AhR stimulated by TCDD helped 
promotion of cancer and expanded the already initiated clone to produce cancer 
(Ellinger-Ziegelbauer et al., 2009). On the other hand, PAHs are AhR ligands 
metabolised by CYP1A1 into more toxic intermediates that induce damage to the 
DNA, that is to say genotoxic carcinogens. In addition, this is a second mechanism 
to induce cancer by activation of AhR. Regarding the crosstalk between AhR and 
7*)ɜ$K5 QXOO DQLPDOV VKRZHG DQ LQFUHDVH LQ WKH OHYHO RI 7*)ɜ 7KLV IDFWRU
regulates development, cell migration and apoptosis (Gomez-Duran et al., 2009). 
In rat models, continuous ingestion of TCDD for 2 years resulted in cancer of the 
lung, liver, plate and nasal turbinates. It is calculated that 1 ng per kg body weight 
per day for 2 years is sufficient to cause risk of developing cancer (Kociba and 
Schwetz 1982). To explain species difference in sensitivity to cancer, the ligand 
binding domain polymorphism and the C terminal region of AhR are responsible 
for different responses to the same ligand. Induction of CYP1A1 and CYP1A2 is 
linked to cancer production (Qian et al., 2010). These enzymes are related to 
increased metabolism of oestrogens and increase free radical production, which is 
indeed genotoxic. These data may explain why female rats are more susceptible to 
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hepato-carcinoma than males or humans, where CYP1A1 induction is less than in 
female rats (Schwarz and Appel 2005). In humans, the risk of cancer is less than 
rodents, but is related to lung, gastro intestinal tract cancers, soft tissue sarcoma, 
breast carcinoma and non-Hodgkin lymphoma (Safe 2001). 
 
1.10 Evolution of toxic AhR 
PAS-domain containing proteins are found in various organisms like animals, 
plants, fungi, bacteria and archea (Crews 1998; Pellequer et al., 1998; Somers et 
al., 2000). However, AhR domains exist in metazoans, and are diverse in multiple 
phyla, and in different species from which extensive genetic and developmental 
research has been performed. AhRs are present in many animal species, which 
provides the potential to study AhR function and evolution in a broad scope of 
organisms from metazoa to humans. These AhR candidates have common 
structural and functional properties considering some distinct criteria. Moreover, 
these features are considered as an evolutionary maturation of the function of AhR 
from metazoa to the complex adaptive functions in higher animals or humans, and 
explain how these chemicals interact with their receptors mediating ligand 
function and inducing toxicity (Hahn 2002).  
 
The cDNAs of AhR have been successfully cloned from the genomic DNA of 
many mammalian strains and extensive molecular and biochemical studies on AhR 
proteins have been carried out in these different species with special interest in 
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mouse and human AhR (Hankinson 1995; Schmidt and Bradfield 1996; Hahn 
1998). In mouse strains, minor polymorphism in amino acid sequences induces 
major differences in receptor binding affinity and subsequent functional effects, 
which could explain why each species member differs in response to dioxin 
toxicity (Ema et al., 1994; Poland et al., 1994; Wong et al., 2001). AhRs from 
other mammalian species have not been as well characterised or biochemically 
studied, and may have similar physiological properties (Gasiewicz et al., 2008; 
Vuori et al., 2008). AhR cDNA sequences of the very sensitive guinea pig and the 
very resistant hamster have been studied (Dencker 1985; Olson 1986; Gassmann et 
al., 2010). However, it is difficult to understand how polymorphisms in the ligand 
binding domain and the C terminal can explain the observed thousand-fold 
difference in sensitivity to dioxin. The AhR size varies from 95 to 125 kDa in 
various vertebrates. Furthermore the amino acid sequence is different from one 
animal to another. On the other hand, the N terminus structure is more 
conservative. The TAD (the Trans Activation Domain) shows both inter and intra 
species variation that reflects variable response to dioxin toxicity. The LD50 of 
TCDD in guinea pig is 1µg/kg, yet the LD50 in hamster is 1mg/kg. The DBA2 
strain of mouse is 14 times more resistant than the C57BL6 strain; this is explained 
by an amino acid polymorphism in the AhR ligand binding domain. In addition, 
Han-wistar rats are 1000 times more resistant than Long-Evans rats. This is 
explained by a point mutation in the TAD. The resistant hamster TAD is long with 
more glutamine amino acids than sensitive species. Both TADs of guinea pigs and 
Ahmed Helaly                                                                                      Introduction                            
 
37 
 
humans look similar. The C-terminus ends of human and mouse AhR share 
identity of 58% in contrast to the highly conservative N-terminus (Ramadoss and 
Perdew 2005). Another area of research on AhR diversity is the presence of AhR 
polymorphisms in humans that affect the expression of CYP1A1 and contribute to 
the susceptibility to lung cancer. Four single nucleotide polymorphisms (SNPs) 
and the subsequent changes in amino acid sequence of the human AhR protein in 
the C-terminal TAD (exon 10) have been identified (Kawajiri et al., 1995; 
Watanabe et al., 2001; Harper et al., 2002; Rowlands et al., 2010). It is not clear 
how these polymorphisms play a role in dioxin susceptibility, CYP1A1 expression, 
chloracne or cancer production (Kawajiri et al., 1995; Anttila et al., 2000; Smart 
and Daly 2000). Yet, a study carried out on proteins translated by human AhR 
alleles having more than one SNP in a combination of two or three SNPs resulted 
in decreased induction of CYP1A1 gene transcription (Wong et al., 2001). 
However, the clinical application of these results is yet to be established. 
Some marine species, like mouse strains, are extremely sensitive to dioxins. Their 
AhR binds to ligands with higher affinities than other species, and unfortunately 
they are exposed to a high amount of dioxins and other AhR agonists. This raises 
the question about the high risk of environmental toxicity of dioxins in the seas.  
1.10.1 Birds, reptiles and amphibians 
Studies have been applied to avian AhRs, where chickens were subjected to dioxin 
intoxication, and extensive research undertaken and updated every day (Head and 
Kennedy 2010). Some birds living near water are in danger of intoxication from 
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environmentally-stable dioxin and its related compounds (Gilbertson et al., 1991). 
As mentioned previously, there is a wide range of levels of affinity to dioxins in 
different types of birds, indicating the importance of molecular research on AhR in 
these animals (Karchner et al., 2006; Pirard and De Pauw 2006; Head and 
Kennedy 2010). Biochemical research on chicken AhR showed that they are 
sensitive to dioxin toxicity due to high TCDD binding affinity (Sawyer et al., 
1986; Karchner et al., 2006). Biochemical characterisation of AhR in birds is still 
primitive. The full length sequences of AhR are available only in 2 species, 
chicken and common tern (Karchner et al., 2000; Head and Kennedy 2010). Even 
less research data is available about AhRs in amphibians and reptiles. AhRs have 
been identified in newt (Marty et al., 1989) and a turtle (Hahn et al., 1994). The 
cDNA of AhR has been cloned from mudpuppy (Karchner et al., 2000) and a frog 
(Collier et al., 2008). The frog AhR still has the similar regions to fish AhR, 
however, it weakly binds TCDD. The sequence of frog AhR has similar domains 
like vertebrate AhR except the TAD. More research work is needed to characterise 
these proteins and perform functional and molecular studies on them (Lustig and 
Kirsten 1974; Jonsson et al., 2011). 
1.10.2 Fish 
Fish have high binding affinity of TCDD to their AhRs, mediating extensive 
environmental toxic effects. The highest effects of dioxin on fish occur during 
embryonic development (Hahn et al., 1997; Abalos et al., 2010; Kawakami et al., 
2010; Zhou et al., 2010). This is why fishes, especially zebra fish, are considered 
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good candidates to study dioxin effects, mechanisms and functions (Andreasen et 
al., 2007; Jonsson et al., 2007). On the other hand, it is demonstrated that fish are 
biologically different to mammals. Fish possess at least two AhR genes, 
expressing AhR1 and AhR2 proteins. These findings were first discovered in the 
estuarine killifish, Fundulus heteroclitus (Hahn et al., 1997; Powell et al., 2000; 
Patel et al., 2006), and it is now known that Zebra fish has AhR1 and AhR2 
subtypes unlike a single AhR gene in mammals. AhR1 is more similar to 
mammalian AhR than AhR2, but both AhRs have bHLH, PAS-A and PAS-B 
domains (Jonsson et al., 2007).  
Phylogenetic analysis (Powell and Hahn 2000; Yamauchi et al., 2005; Yasui et al., 
2007; Zhou et al., 2010) and gene mapping (Karchner et al., 2002; Evans et al., 
2005) showed that fish AhRs are homologues of mammalian AhR. Furthermore, 
AhR2 seems to be the main AhR protein in fish for binding exogenous ligands 
(like mammalian AhRs), according to cloning and expression experiments 
(Karchner et al., 1999; Goldstone et al., 2009; Merson et al., 2009). In general, fish 
AhR1 and AhR2 have biochemical criteria that are similar to those of mammalian 
AhR. These molecular properties include dioxin-binding with high affinity, 
dimerisation with ARNT and AIP interaction with xenobiotic response elements 
and transcription of a battery of genes mediating the action of dioxins (Law 2001; 
Finn 2007; Jonsson et al., 2007). However, both transactivation domains of AhR1 
and AhR2 are different in structural motifs (Tanguay et al., 2000; Necela and 
Pollenz 2001; Andreasen et al., 2002) suggesting that the two fish AhRs may have 
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different functions (Karchner et al., 1999). From the evolutionary point of view, it 
is supposed that complex gene functions in mammals are split in separate genes in 
fishes (Evans et al., 2005; Yasui et al., 2007; Zhou et al., 2010). Table 1 
summarizes the differences between different AhRs in various species.  
Table 1. Comparison of different properties of AhRs in different species. 
AhR C. elegans Mollusc Arthropod Vertebrate1 Vertebrate2 Vetrebrate AhRR 
bHLH yes yes yes yes yes yes 
PAS domain PAS-A,B PAS-A,B  PAS-A,B PAS-A,B PAS-A,B PAS-A,B 
Q rich domain No yes yes yes No No 
Specific Binding to  
[H
3
]TCDD No Nd nd yes yes nd 
Binding to hsp90 yes Nd nd yes nd No 
Binding mouse ARA9 No Nd nd yes yes nd 
Dimerizes with ARNT yes yes yes yes yes yes 
Binds AhRE yes yes yes yes yes yes 
Transcriptional activity Activator Nd Activator Activator Activator Repressor 
 
1.11 Invertebrates 
The Caenorhabditis elegans (nematode) genome project comparative study 
showed that C. elegans has an AhR ortholog to mammals (CeAhR). Following 
that, an AhR candidate was detected in the arthropod, Drosophila melanogaster 
(Duncan et al., 1998; Emmons et al., 1999). Recently, several molluscs have been 
found to express AhR genes (Butler et al., 2001). Invertebrate animals exhibit 
substantially major differences to vertebrate and mammalian AhRs in that 
invertebrate AhR is not known to bind dioxins (Hahn 1998). Therefore, the 
existence of an AhR candidate in invertebrates is a point of interest that explains 
the evolution of the function of AhR from one species to another. 
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1.11.1 Drosophila melanogaster 
D. melanogaster expresses AhR protein, DmAhR, which is an 884-amino acid 
sequence. It has, like other AhR homologs, a bHLH domain, which has similar 
structure to mammalian AhRs. The bHLH is a common structure identity among 
different types of AhRs and that in DmAhR shares a 71% structural identity with 
mammalian bHLH. The PAS-B domain of DmAhR shares a sequence identity of 
45% with mammalian AhRs (Duncan et al., 1998). DmAhR has a Q-rich domain 
in its C-terminal half that corresponds to the mammalian transactivation domain, 
while this feature does not exist in CeAhR. DmAhR interacts with the tango 
protein (DmARNT) in a yeast two-hybrid assay, and the DmAhR–DmARNT 
complex can activate a DNA-dependent reporter gene in insect cells that does not 
require ligands (Emmons et al., 1999). Furthermore, DmAhR protein is not found 
resting in the cytoplasm, like mammalian or even C. elegans AhRs. It is assumed 
that DmAhR is active without ligands and spontaneously translocates to the 
nucleus, which may explain the existence of this originally cytoplasmic protein in 
the nucleus (Butler et al., 2001). 
Experimental studies to characterise the function of DmAhR were carried out. A 
mutated AhR model was created and the animal phenotype showed transformation 
of the distal antenna into leg structures; the legs were lacking the distal segment, 
while the bristles were small in size. These structural changes were corrected by 
restoration of AhR function. Experimental work claimed that DmAhR controls 
distal-less(dll) (Duncan et al., 1998), the gene that controls flies appendage 
Ahmed Helaly                                                                                      Introduction                            
 
42 
 
maturation (Panganiban 2000), and bric-a brac (bab) is then regulated by the AhR; 
bab is the transcription factor that controls the maturation of appendages and 
ovaries. The sexually dimorphic maturation in D. melanogaster is indirectly 
regulated by AhR through the control of bab transcription (Kopp et al., 2000; 
Bunger et al., 2003). The corresponding DLX genes in the mammal that have 
similar function to dll are not known to interact with mammalian AhR. On the 
other hand, DLX genes are responsible for shaping the craniofacial structure and 
affect teeth maturation. These places are targets for dioxin toxicity in humans (Qiu 
et al., 1997; Thomas et al., 1997; Hornung et al., 1999; Kattainen et al., 2001; 
Bunger et al., 2003). 
DmAhR and CeAhR play a role in the maturation of chemoreceptive neurons. This 
invertebrate role of AhR corresponds to the xenobiotic metabolic function of AhR 
in mammalians. This may be considered an evolutionary advance in the function 
of AhR from invertebrates to mammals (Duncan et al., 1998; Emmons et al., 
1999). 
1.11.2 Molluscs 
Recently, AhR corresponding genes have been discovered in molluscs; for 
example, the soft shell clam, Mya arenaria (Butler et al., 2001), the zebra mussel, 
Dreissena polymorpha (Hahn 2002), and the blue mussel, Mytilus edulis (Hahn 
2002). The mollusc AhR homologue contains bHLH and PAS domains like 
invertebrate AhRs, and is capable of binding the mammalian DNA response 
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element. Like CeAhR, binding studies failed to demonstrate AhR ligands (Butler 
et al., 2001). 
 
1.12 Recombinant expression of AhR and AhR-1 for structural studies 
Human and mouse AhR has been subjected to recombinant expression. However, 
the outcome of expression in bacterial systems was completely insoluble AhR (Fan 
et al., 2009). Full length human and mouse AhR have been expressed in SF9 insect 
cells. The insect cell system expressed recombinant mammalian AhR in abundant 
amounts. The expression of AhR LBD was also successful, yet the amount of 
protein expressed was less than the full length. Studies carried out on rats showed 
that recombinant AhR could bind ligands including TCDD, however, the major 
obstacle facing crystallization was the fact that most of the expressed protein was 
insoluble  (Jiang et al., 2009). Co-expression of p23 co-chaperone did not increase 
the production of the protein or improve its solubility. The major problem was not 
related to the quantity of expressed AhR protein but the expression of soluble 
folded mammalian AhR; most of the AhR expressed was insoluble. This makes it 
extremely difficult to purify enough soluble protein for crystal structure study. The 
3-dimensional structure of mammalian AhR has been a major obstacle for many 
years (Fan et al., 2009). 
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1.13 Previous AhR and AhR LBD models 
Studies of expression of mammalian AhR resulted in non-soluble AhR. It was 
difficult to obtain a soluble functional AhR for crystal structure analysis, despite 
the many studies on different expression systems. In order to overcome this 
problem, computer-based models have been generated to make it possible to 
understand how AhR binds its ligands. The first trial started 15 years ago by 
creating a model of AhR utilizing the structure of TCDD as a template for AhR 
ligands (Waller and McKinney 1995). The weak point of that ligand-based model 
was because of the ability of the AhR LBD to bind a very wide range of ligands of 
different structure making this first computer-based model perhaps too speculative. 
The new theory of AhR modelling depends on the available PAS domain 
structures. It is known that PAS domain proteins are conservative in structure, 
despite the diversity of the primary protein structure. This advantage makes any 
success in discovering a new PAS domain protein structure a breakthrough in the 
computer modelling of AhR. Any addition of crystal structure will produce a more 
realistic model. It is thought that the template proteins with 40% similarity and 
similar biochemical properties have similar structure (Chang et al., 2010; Kikani et 
al., 2010; Kumauchi et al., 2010; Partch and Gardner 2010). 
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Figure 6. The modeled mouse AhR LBD based on mod_HIF/ARNT as a template. Residues 
with side chains pointing outside the modelled LBD are blue in colour; residues at the 
boundaries of the cavity with pink side chains were subjected to mutagensis study; Ile332, is 
yellow. The green cavity represents the ligand binding domain. The computer-generated 
model based on these templates was applied using MODELLAR version 8 v1 program. The 
secondary structure of the AhR LBD was predicted by PSIPRED. The PROCHECK program 
was used to validate the model. The CASTp server was used to evaluate the AhR LBD pocket 
(Pandini et al., 2007). 
 
The model shown in Figure 6 is based on template PAS domain structures of HIF 
alpha2, ARNT, human PAS kinase, human erg potassium channel (HERG), 
Drosophila clock protein PERIOD, Adiantum capillus-veneris chimeric 
phytochrome/phototropin photoreceptor, mouse receptor coactivator 1A (NCoA), 
Bradyhizobium japonicum sensor protein FixL (FixL) and the Ectothiorhodospira 
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halophila photoactive yellow protein (PYP). These data were obtained from the 
protein data bank. (Pandini et al., 2007).  
 
 
 
Figure 7. The computer-based mouse AhR LBD modelling performed by Bisson et al. (2009).  
The green area represents the beta sheets that accomodate the ligands. The ICM function was 
applied for homology modelling. ICM pocket finder was used to outline the AhR LBD. The 
modified ECRPP/3 energy function was applied to outline the side chains and the different 
chemical bonds (Cardozo et al., 1995; Bisson et al., 2009).  
 
The model shown in Figure 7 was constructed based on the available HIF alpha2 
PAS domain protein structure existing in the Protein Data Bank (PDB) as a 
template. The sequence similarity with mouse AhR LBD was about 30%.  
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Figure 8. The AhR computer-based model created by Jolalekar et al. (2010) with alignment 
(below) of mouse AhR (top) and HIF alpha2 (bottom). The highted amino acids are identical 
between AhR and HIF alpha2. To create this model, Astrex ASP scoring function and the post 
docking MM-GBSA were applied. 
 
The model shown in Figure 8 was based on HIF alpha2. TCDD and 17 other 
ligands were investigated by computer-based docking (MM-GBSA). This 
approach uses a combination of computer-based receptor and ligand templates for 
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the creation of an AhR LBD model. It is hoped that such models would be more 
compatible with the real AhR LBD (Jogalekar et al., 2010). 
 
1.14 C. elegans AhR 
AhR plays a role in the development of invertebrates. Studies showed an essential 
function in neural development (Vuori et al., 2008). Other studies showed that C. 
elegans AhR-knockout animals have clear neuronal defects in the form of aberrant 
cell migration and axonal branching. These changes affect neuron differentiation, 
especially the touch receptor neurone, AVM (Qin and Powell-Coffman 2004). 
The C. elegans AhR-1 (CeAhR) consists of a 602-amino acid protein that has an 
overall 38% amino acid identity with human AhR (HsAhR) with the best similarity 
over the first 395 amino acids (Figure 9) (Powell-Coffman et al., 1998). It is also 
known to mediate DNA binding, dimerisation with ARNT, and interaction with 
Hsp90, but is not thought to bind to known mammalian AhR ligands (Powell-
Coffman et al., 1998). It is supposed to work as a transcription factor that regulates 
the development of the nervous system of C. elegans. Studies to mutate CeAhR 
showed that the animals were suppressed in aggregation behaviour. The function 
was restored when the gene function was expressed back (Qin et al., 2006). The 
CeAhR protein shares the structural and biochemical properties with mammalian 
AhR (Figure 9). CeAhR possesses a bHLH domain contained within the specific 
amino acid sequences that are conserved in mammalian AhR. PAS domains exist 
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in CeAhR, i.e. PAS-A and PAS-B domains. CeAhR could thus be considered a 
model for the mammalian AhR. 
  
Figure 9. Comparison between mouse AhR as a representation of a mammalian AhR and the 
C. elegans AhR. The green box represents the AhR ligand binding domain, which shows 
about 46% similarity with the corresponding domain in the mouse. 
 
Recombinant expression of CeAhR revealed that it is capable of binding ARNT 
(Powell-Coffman et al., 1998). Interestingly, it is assumed that CeAhR can bind 
the DNA response element without interaction with xenobiotic ligands. However, 
these findings could also be seen in mammalian AhR (Dolwick et al., 1993; Jensen 
and Hahn 2001), fish AhR (Karchner et al., 1999) and other invertebrate AhRs 
(Butler et al., 2001). On the other hand, CeAhR does not bind AIP in contrast to 
human AhR (Bell and Poland 2000). The C-terminal half of the CeAhR works as a 
transcriptional activator; however, its structure is quite different from the 
corresponding mammalian domain, and it is thought that the PAS domain inhibits 
the transactivation domain in a consistent manner. Post-translational modification 
is required for that domain to properly function (Powell-Coffman et al., 1998).  
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Experimental studies carried out to evaluate the ability of CeAhR to bind ligands 
showed that recombinant expressed C. elegans AhR could not bind either TCDD 
QRU ȕ-naphthoflavone using ligand binding assay (Powell-Coffman et al., 1998). 
The CeAhR-ligand interaction has been examined by multiple methods. Specific 
labelling of CeAhR by the photoaffinity ligand, [125I]N3Br2DD, could not be 
detected despite its ability to bind mammalian (Poland et al., 1986; Powell-
Coffman et al., 1998) and fish AhRs (Hahn et al., 1994). Other experimental 
studies using the reversible radioligands [3H] TCDD in velocity sedimentation 
have evaluated CeAhR ability to bind ligands, but the results were negative. The 
CeAhR is not known to bind any other mammalian AhR ligands (Butler et al., 
2001). The PAS repeat of CeAhR that contains the LBD is very similar to the 
corresponding human AhR. Most current models of AhR used PAS templates that 
are less similar to AhR. The success in obtaining the crystal structure of the PAS 
domain of CeAhR will provide a breakthrough in obtaining a better template to 
generate a more realistic AhR model, which is more accurate than the published 
ones. Furthermore, the biochemical properties of CeAhR are closer to those of 
human AhR than other PAS domain proteins. CeAhR binds human ARNT, and 
CeAhR can activate the human xenobiotic DNA response element (Huang et al., 
2004; Qin and Powell-Coffman 2004). It is logical to say that the best AhR model 
will be based on a CeAhR template. 
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1.15 Aim of the study 
It is important to say that TCDD toxicity is not only dependent on AhR binding, 
but may also be related to the ligand position within the ligand binding domain. It 
is thought that changes in ligand position determine whether agonist or antagonist 
effects are caused by a specific ligand. So 3-dimensional structure analysis will be 
very important in understanding the mechanism of action of the AhR receptor and 
its response to different ligands (Henry and Gasiewicz 2008). 
It is vital to understand the binding of ligand to AhR, as it is not well understood 
even now (Dzeletovic et al., 1997; Vuori et al., 2008). Crystallography and 
structural analysis of AhR is an important step to visualise how AhR protein 
works. Unfortunately, trials to express mammalian AhR have failed to express 
AhR protein in a soluble form that is suitable for crystallography. CeAhR has 
structural and biochemical properties similar to mammalian AhR (Powell-Coffman 
et al., 1998). As a result, it is considered a good model for mammalian AhR, and 
hopefully crystallography will be easier to achieve, allowing 3-dimensional AhR 
analyses. Therefore, the aim of this study is to express the LBD of CeAhR (the 
most important part in ligand binding) initially in bacteria or in other systems if 
this is unsuccessful. The next step will be to purify soluble CeAhR LBD after large 
scale expression. Finally, attempts will be made to crystallize the protein and 
submit it for X-ray diffraction studies to determine its structure. 
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2 MATERIALS AND METHODS 
2.1.1 Chemical reagents  
 
All common chemical reagents were of analytical grade and were obtained from 
Sigma-Aldrich (Germany), Melford Laboratories (UK) or Fisher Scientific (UK). 
Yeast extract was from Difco Laboratories (USA), Lysozymes and glycerol were 
obtained from Courtin & Warner (UK), buffers for DNA digestion were purchased 
from New England Bio labs (USA), His Binding resin was from Novagen 
(Germany) and PCR Master Mix and PCR Ready Mix were from GE Health Care 
(UK). 
2.1.2 AhR agonists 
AstraZeneca compound 1c (AZ1c; 3-hydroxy-2-[4-(trifluoromethyl)phenyl]-
[1,2,3]-triazolo[1,5-a]quinolinium hydroxide; Fig. 10) was from AstraZeneca 
(UK). TCDD (2,3,7,8-tetrachlorodibenzo-ɪ-dioxin), 3MC (3-methylcholanthrene) 
and PCB126 (3,3`,4,4`,5-pentachlorobiphenyl) (Fig. 10) were from Cambridge 
Isotope Laboratories. 2-(4-amino-3-methylphenyl)benzothiazole (AMB) (Aylward 
et al., 2005) DQGȕ-naphthoflavone (Fig. 10) were from Sigma. 
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Figure 10. 2-D structures of the AhR ligands used in lethality tests with C. elegans. 
 
2.1.3 Antibodies 
Monoclonal anti His tag HRP mouse antibodies were from Sigma (Germany) and 
anti-GST HRP conjugate was from GE Healthcare (UK). 
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2.1.4 Enzymes 
The enzymes used in this work; zymolase, lysozymes, DNAse1, restriction 
digestion enzymes (BamH1, Sac1, Nhe1, Xba1, EcoR1, Pvu2, etc.), DNA Ligase, 
Taq polymerase and RNA reverse transcriptase were obtained from New England 
Biolabs (USA). 
 
2.1.5 Kits for molecular biology 
Miniprep kit, Maxiprep kit, Gel purification kit and DNAse kit were from Qiagen. 
RNA /cDNA Kit was from Stratagene. 
 
2.1.6 Microorganism Strains  
x E. coli (PL21DE3, Arctic Express, JM109, SCS111, PO4 50) 
x Pichia pastoris Strain JM115 Mut+ 
x C. elegans N2 
x C. elegans GFP 34 A9, 35 A2, 29 A2 strains 
x AhR-1 null C. elegans (CZ 24 85) 
 
2.1.7  Plasmids and Constructs 
x pRSET A containing C. elegans AhR LBD  
x pPICZ B containing GST C. elegans AhR LBD 
x pPICZ B containing His Tagged C. elegans AhR LBD 
x pPICZ alpha B containing His Taged C. elegans AhR LBD 
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x pPICZ alpha B containing GST C. elegans AhR LBD 
x pPD30.38 containing His Tagged C. elegans AhR LBD 
x pPD30.38 containing GST Tagged C. elegans AhR LBD 
x pET-41b containing C. elegans AhR LBD  
x pGEMT, pGEMT easy Kits 
x pPICZ B from Invitrogen 
x pPICZ alpha B from Invitrogen 
x pET-41b from Novagen 
ppRSET B
AhR-1 LBD
SacȻ
XbaȻ
SacȻ
NheȻ
pPD30.38
pPD30.38
AhR-1 LBD
 
Figure 11. Illustration of the sub-cloning of CeAhR (AhR-1) LBD into pPD30.38 plasmid to 
create a construct ready for microinjection into C. elegans for creating His tagged AhR. 
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GST-AhR
 
Figure 12. Illustration representing the sub-cloning strategy for creating the GST-AhR 
construct in pPD30.38 to be microinjected in C. elegans. 
pET-41b
GST
XbaȻ
SacȻ
pPD30.38
XbaȻ
SacȻ
pPD30.38
GST
XbaȻ
SacȻ
 
Figure 13. Sketch representing sub-cloning of GST tag into pPD30.38. The figure explains 
how GST was lifted from pET-EE\ERWK;EDǿDQG6DFǿUHVWULFWLRQGLJHVWLRQHQ]\PHVWREH
inserted into pPD30.38 creating a control construct. 
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pGEMTpGEMT
EcoRȻ
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AhR-1 LBD
pPICZ B
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EcoRȻ
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pPICZ BpPICZ alpha B
AhR-1 LBDAhR-1 LBD
 
Figure 14. Illustration showing the multiple cloning of CeAhR (AhR-1) LBD with EcoR1 and 
Xba1 sites in pPICZ B and pPICZ alpha B. 
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pPICZ BpPICZ alpha B
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EcoRǿ
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Xbaǿ Xbaǿ
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Figure 15. Sub-cloning of AhR-GST. AhR was lifted from pET-41b plasmid to be cloned into 
both pPICZB and pPICZ alpha B. 
 
2.1.8 Construct design by Vector NTI Suite 7 
The DNA constructs were designed by the Vector NTI 7 program for expression of 
CeAhR LBD protein in the Pichia pastoris expression system. 
 
 
 
 
 
Ahmed Helaly                                                                    Materials and Methods                                                                                                                                 
 
59 
 
2.1.9 Primers 
 
 
Table 2. Primers used in this study. 
1 - Forward (385) 
primer for pPD30.38 
TGC CAA CAT CCT GCG GA 
2 - Reverse (385) 
primer for pPD30.38 
ATA ACA AAA ATA GCG GGT GGG AG 
3 - Forward AhR PCR GA ATT CAC ATG GGA TTT TTG AGA ATT GAC ATG CGC 
4 - Reverse AhR PCR TCT AGA AA TAA TGG AAG TGC AGC TGT TGA TTG GAG 
5 - AOX1 forward  GAC TGG TTC CAA TTG ACA AGC 
6 - AOX1 reverse GCA AAT GGC ATT CTG ACA TCC 
7 - AhR cDNA forward CAT GGA TTA CCA TCA TCG TA 
8 - AhR cDNA reverse TGG TAG ATC AGT TTC ATC AA 
 
2.2 Methods 
2.2.1 E. coli DNA Techniques 
2.2.1.1 Preparation of Agar plates with Ampicillin 
LB agar (tryptone 10g, NaCl 10g, yeast extract 5g, agar 12g) was added to one 
litre distilled water (D.W.) and was autoclaved for 20 minutes. The agar was 
melted in the microwave (15 minutes, 50% power), and then left in a 60°C water 
bath for 20 minutes. At the same time, ampicillin was put in the same water bath 
making the temperature of both the agar and the antibiotic the same. After 20 
Ahmed Helaly                                                                    Materials and Methods                                                                                                                                 
 
60 
 
minutes, the ampicillin was added to the agar liquid to a concentration of between 
50 to 100 Pg/ml. 
 
2.2.1.2 Preparation of chemically competent cells 
A fresh plate was streaked to purity with E. coli (cell type: JM109) then a single 
colony was picked up and grown in 5 ml LB broth (10g tryptone, 10g NaCl, 5g 
yeast extract in 1L distilled water) containing no antibiotic. The cells were left to 
grow overnight in the incubator at 37°C, with shaking at 220 rpm on the orbital 
shaker. The following day, the 5 ml culture was added to larger volumes of LB 
broth, according to the stock needed. An example was adding 5 ml of the cells 
grown overnight to new fresh 50 ml LB broth that was left in the incubator at 37°C 
with shaking at a rate of 220 rpm for 3 hours. The OD was measured at 600 nm 
and the optimum result was 0.6. The cultures were centrifuged at 4000ug for 15 
minutes at 4°C. The supernatant was removed and the pellet re-suspended and 
washed with 50 ml ice-cold sterile 0.1 M CaCl2. The pellet was repeatedly re-
suspended and washed in smaller volumes of ice-cold sterile CaCl2; the final 
volume was a 2 ml suspension. 10% glycerol was added and the volume was 
divided into sub-aliquots of 200 µl bacteria and kept at -80°C for transformation.   
 
2.2.1.3 Transformation of E. coli with PrsetA plasmid containing CeAhR LBD 
1Pl of CeAhR LBD DNA dissolved in water was added to the thawed, chemically-
competent cell aliquot, which was about 200 Pl of suspended cells. The DNA was 
Ahmed Helaly                                                                    Materials and Methods                                                                                                                                 
 
61 
 
mixed with the cells and kept on ice for 2 minutes. The following step was to heat 
shock the mixture at 42°C for 90 seconds, the samples were then transferred to a 
hot water bath at 42°C then rapidly returned to ice for another 2 minutes. This 
rapid change in temperature is intended to allow the DNA to pass through the cell 
membrane of the CaCl2-treated cells. 1 ml of SOC media (20g peptone, 5g yeast 
extract, 2ml 5M NaCl, 2.5 ml 1M KCl, 10ml 1M MgCl2, 10 ml 1M MgSO4  and 
20ml 1M glucose in 1L distilled water) was rapidly added to the cells and the 
whole mixture incubated at 37°C for about 45 minutes. 200 Pl of cells were plated 
on an agar plate containing ampicillin, and then incubated overnight at 37°C to 
allow the bacterial colonies to grow. 
  
2.2.1.4 Qiagen miniprep of the plasmid DNA 
DNA was re-purified from the colonies plated in the previous step to make sure 
that CeAhR LBD-containing plasmid has been successfully transformed into E. 
coli. In order to extract the plasmid DNA a Qiagen Miniprep Kit was employed. 
The experiment followed the kit manual; first, one colony was picked up and 
inoculated into 5 ml ampicillin-containing (100 Pg/ml) LB broth. It was left 
overnight in the incubator at 37°C with shaking at 240 rpm. The next step was 
transferring the culture to Eppendorf tubes, and centrifuging at maximum speed 
(20,000ug) at room temperature for 10 minutes. The pellet was then suspended in 
250 Pl of P1 buffer and mixed well, then 250 Pl P2 buffer was added, and gently 
mixed by inversion of the tube 4-6 times. 350 Pl N3 buffer was then added and the 
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mixture centrifuged at maximum speed (20,000ug) for one minute. The 
supernatant was taken and pipetted into the QIAprep spin column. This column 
was centrifuged again at maximum speed (20,000ug). The column was then 
washed by adding 750 Pl Buffer PE to the column and centrifuging at maximum 
speed (20,000ug) for one minute. After that, the column was removed and put in a 
new Eppendorf tube where 50 Pl of elution buffer was added and left for 1 minute, 
then centrifuged at maximum speed (20,000ug) for 1 minute to get a final volume 
of 50 Pl containing the desired DNA. 
 
2.2.1.5 Restriction digestion 
The pRSET plasmid DNA was digested by BamH1 restriction digestion enzyme. 
This enzyme works at 100% activity in Buffer 4. The volume of the reaction was 
20 Pl of the cocktail including 10% enzyme by volume. 4 Pl of DNA was added to 
the reaction and the mixture volume completed with buffer, BSA 100 mg/ml and 
water. The reaction was incubated at 37°C in a water bath for one hour. 
 
2.2.1.6 DNA Gel Electrophoresis 
50 ml of 1% agarose was prepared by adding 0.5 mg agarose powder to 50 ml 
TAE buffer (40mM tris acetate, 1 mM EDTA); then the mixture was heated in the 
microwave oven at 50% power for 1-5 minutes. The solution was checked and 
found to be clear. The following step was to transfer the solution to a 60°C water 
bath, then load it onto the gel cassette with suitable combs, and leaving it at room 
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temperature for 20 minutes until the gel settled. The digested DNA was loaded to 
the gel with a suitable DNA Marker (1kb plus). The next step was to load the DNA 
to the combs and run electrophoresis at 80 volts for 45 minutes, with the negative 
electrode near the comb (DNA) site. 
 
 
2.2.1.7 pRSET Plasmid amplification 
200 Pl of chemically-competent E. coli cells (JM109) were prepared and 
transformed with 1Pl pure Prset Plasmid containing the CeAhR LBD. The cells 
were incubated on ampicillin-containing agar plates at 37°C for 24 hours. The 
following day, one or more colonies were picked up and grown in LB broth 
containing 50 to 100 Pg/ml ampicillin for another day, where the culture was 
incubated at 37°C with shaking at 220 rpm overnight. The growing cells were 
mini-prepped according to the Qiagen Kit protocol. The presense of the CeAhR 
LBD fragment was confirmed by digestion and electrophoresis. The amount of 
DNA was estimated by the Nano Drop 1000 Spectrophotometer (V 37). At 260 nm 
wavelength each 50 Pg/ml DNA gives 1 absorbance unit. From this, linear 
comparison with the sample absorbance reflects the amount of DNA in the sample. 
 
2.2.1.8 Ethanol precipitation of DNA 
For each volume of DNA, ½ volume of 7.5 M ammonium acetate was added, then 
double the resultant volume of 100% ethanol was added and the mixture frozen at 
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-20 °C for at least 1 hour. The sample was thawed then centrifuged at the 
maximum speed (20,000ug) for 30 minutes. The supernatant was discarded, and 
the pellet washed with 70% ethanol for one minute, then the sample was 
centrifuged again for another minute. The remaining fluid was removed keeping 
the pellet at the bottom of the tube. The pellet was left to dry for 5 minutes and 
then ultra pure water was added to dissolve the DNA to the appropriate volume of 
about 10µL. 
2.2.1.9 DNA ligation reaction setup 
The ligation reaction is an overnight reaction, and is set up using the following: 
x 1 Pl of 10x ligation buffer from pGEMT kit 
x 1Pl of DNA ligase from pGEMT kit 
x 8 Pl of vector/insert mixture. 
The ratio between the insert and vector should be at least 3:1. Different ratios were 
made empirically for best results. 
 
2.2.2 QIAquick Gel Extraction Micro centrifuge Protocol 
All experimental work was done at room temperature. 4 times volume of 100% 
ethanol was added to Buffer PE and the bottle marked accordingly for further use, 
and a 50°C water bath made ready. The centrifuge was ready at (18,000ug). The 
protocol to extract the DNA continued by weighing the gel fragments inside the 
Eppendorf tube, and adding 3 times the volume of Buffer QG. Each 100 mg weight 
was considered a 100Pl volume. The tube containing the gel and Buffer QG was 
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incubated for 10 minutes in a 50°C water bath. The next step was making sure that 
the gel had dissolved and that the mixture colour was yellow. Then an equal 
volume of isopropanol was added to the mixture. The mixture was transferred to 
the QIAquik spin column in the 2 ml collection tube provided. The sample was 
centrifuged for 1 minute and the flow-through discarded, then the column was 
returned to the collection tube, as the DNA was supposed to stick to the column. 
The maximum volume of the column is 800 Pl; so if the sample volume was more 
than that, then centrifugation was repeated more than once. 0.75 ml of Buffer PE 
was added as a washing step, and the sample was centrifuged for 1 minute and the 
flow-through discarded. The column was returned to the collecting tube again. The 
DNA was left in Buffer PE for 2-3 minutes before centrifugation for the ligation 
reaction process. After that, the column was transferred carrying the washed DNA 
to a new clean 1.5 ml Eppendorf tube. 50 Pl of Buffer EB (10mM Tris-HCl, pH 
8.5) or water was added as an elution step to the centre of the column for 1 minute 
then the sample was spun for another minute. The purified DNA was measured by 
the Nano drop machine or subjected to gel electrophoresis for further evaluation. 
The purified DNA was mixed with 5 times DNA loading dye and added to agarose 
gel and run for 45 minutes to check for the existence of the purified DNA. 
 
2.2.3 Preparation of electro competent cells  
A single colony of E. coli (JM109) was picked up from fresh plate, and grown 
overnight in 5 ml LB broth. The following day, the growing bacteria were diluted 
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in 50 ml LB and incubated at 37°C with vigorous shaking at about 220 rpm for 
two hours. The OD, which is supposed to be 0.6 at 600 nm wavelength, was 
checked and if it was higher it was essential to dilute the sample and incubate it 
with shaking again until the optimum OD was obtained. It is known that the 
doubling time for E. Coli is 20 minutes.  
Following that, the cells were spun in the centrifuge, and re-suspended in the same 
volume of autoclaved ultra purified water at 4°C. The cells were kept in ice for 10 
minutes and spun again before washing with water. Washing was repeated 5 times 
in the same manner. In the final wash, the volume of water was reduced to 3 times 
the volume of the pellet that was estimated roughly with naked eye. Fresh electro 
competent cells could be used for transformation, or 10% glycerol added, and the 
cells frozen in aliquots for later transformations. 
 
2.2.4 Electroporation of DNA into competent JM 109 cells 
The electroporator was set up for E. coli using an applied voltage of 1.8 kV. 40 Pl 
of cells were loaded into 1cm3 volume cuvettes and voltage applied to the DNA 
until a ring was heard. The time constant was measured by the machine and this 
should be at least 4 seconds; for clean competent cells, the time constant should be 
around 5 seconds. As the DNA solution contains salts from buffers that reduce the 
time constant, it was best to dilute 1 Pl of the DNA into 10 Pl ultra pure water and 
another 1 Pl of the diluted DNA was taken and mixed with cells in ice-cold 
cuvettes, before applying voltage to them. Immediately after applying the electric 
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current, the cells were rescued with 800 Pl SOC medium. The cells were incubated 
in a 37°C water bath for 45 minutes. The next step was to plate the cells on 
ampicillin agar plates and spread them; each plate carrying 200 Pl cells. They were 
left to dry and incubated for 24 hours at 37°C then checked for growing colonies 
the next day. The colonies were picked up, grown overnight and mini-prepped as 
in section 2.2.1.4. The extracted DNA was doubled digested with suitable 
restriction digestion enzymes to check if the insert was integrated in the new 
plasmid or not. There were multiple controls that were set up to detect 
transformation success. First, the electroporated cells without DNA represented the 
negative control. An ampicillin resistant plasmid with known concentration was 
subjected to voltage as transformation efficiency control. Transformation 
efficiency was calculated by counting how many colonies appeared per 
transformation of 1Pg DNA. The electroporation efficiency was supposed to be 
1x108 per 1 Pg DNA transformed. For example, in transforming 1 picogram of 
known ampicillin resistant plasmid DNA, it would be expected to find 100 
colonies in the plate the following day. This was a positive control that evaluates 
the success of transformation of DNA inside healthy competent cells. To evaluate 
the success of the ligation reaction, there were other controls. First, re-ligated, 
single one end digested CeAhR DNA vector could be transformed to evaluate the 
efficacy of the ligase enzyme and health of the cloned DNA ends. The double 
digested vector could be treated by ligase enzyme and transformed as a 
background control. On the other hand, an agarose gel was run to see the band of 
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re-ligated DNA, of the size equal to both vector and insert, to make sure that the 
DNA had been successfully cloned into the selected vector. 
 
2.2.5 Plasmid Maxiprep using QIAGEN Kit 
A single colony was picked up and grown in 5 ml LB broth with suitable antibiotic 
as a selection method for the target plasmid. The sample was incubated at 37°C 
overnight with vigorous shaking (240 rpm). The 5 ml culture was diluted in 
another 500 ml LB containing the selective antibiotic for another night. The 
sample was centrifuged at 6000ug for 15 minutes at 4°C on a JA-10 Beckman 
rotor. The pellet was re-suspended in 10 ml Buffer P1. The cells were completely 
re-suspended without remaining debris either by vortex or pipetting up and down. 
Another 10 ml of Buffer P2 was added and mixed well with cells by inverting the 
collecting tube or flask 4-6 times; the sample was then left at room temperature for 
5 minutes. 10 ml of Buffer P3 was added and gently but rapidly mixed by 
inverting 4-6 times; this time, the sample was incubated in ice for 20 minutes. The 
mixture was then centrifuged at the maximum speed (20,000ug) for 30 minutes at 
4°C. The supernatant containing the target DNA was separated, and centrifuged 
again at the same speed for another 15 minutes. Then, the supernatant containing 
the plasmid DNA was taken off. The gravity column was prepared, and 10 ml 
Buffer QBT added. The supernatant was filtered through the column by gravity. 
The column was then washed with buffer QC. The column was loaded twice with 
30 ml buffer to wash the entire DNA. The plasmid DNA was eluted by adding 15 
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ml of Buffer QF. The DNA was precipitated by adding 0.7 volumes of isopropanol 
and mixing gently at room temperature. Following that, the DNA was spun rapidly 
at 15,000ug for 15 minutes at 4°C, and the supernatant carefully removed. The 
pellet was washed with 70% ethanol at room temperature, and the sample spun at 
15,000ug for 10 minutes. The supernatant was discarded keeping the pellet at the 
bottom of the tube. The final step was to leave the DNA pellet to dry for 5 
minutes, and then it was dissolved in water or suitable buffer (e.g. 10 mM Tris-
HCl, pH 8). The DNA was analysed using agarose gel electrophoresis. 
 
2.3 Protein Techniques in E. coli 
2.3.1  SDS-PAGE Gel Electrophoresis  
100 ml acrylamide gel mix was made up as follows: 
 
Table 3 
Chemical Running Gel Stacking Gel 
Acrylamide (33%) % of gel x 3.33 ml 1.3 ml 
1.5 Tris-HCl pH 8.8  25 ml - 
0.5 Tris-HCl pH 6.8 - 2.5 ml 
10% SDS 1 ml 0.1 ml 
10% ammonium persulphate (fresh) 0.5 ml 0.05 ml 
TEMED 0.05 ml 0.01 ml 
D.W. to 100 ml to 100 ml 
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(TEMED is NNN’N’-tetramethylethylenediamine) 
The solutions were filtered and stored at 4°C in the fridge. Fresh 10% ammonium 
persulphate was added to the remaining solution combination just prior to use. 
Generally, for each gel, 5 ml running gel and 2 ml stacking gel were needed.  
To prepare the gels, clean glass plates with a spacer in between were prepared so 
as to assemble the gel in the created space. The glass plates should be clean, dry 
and sealed, so as to retain the gel material in the space between the two plates of 
each cassette. 100 Pl of 0.1 % SDS was poured rapidly to cover the surface of the 
running gel. Following that, the gel was left to set for 20 minutes at room 
temperature. After that, the gel was confirmed for polymerisation, and the 
overlying SDS solution removed. 2ml of stacking gel was prepared by adding 50 
Pl 10% ammonium per sulphate which was then loaded onto the gel cassette. The 
stacking gel was supposed to reach near the top of the smaller glass plate. Rapidly, 
the comb was added to the space between the two glass plates and allowed to set. 
 
2.3.1.1 Electrophoresis  
The BIO-RAD container was assembled with either one or two gel cassettes, and 
immersed in 1x running buffer (composed of 28.8g glycine, 6.04g Tris base, 2g 
SDS, 1.8 litre dd water). The inner tank should be covered with buffer to the top of 
the small plate. The combs were removed before sample loading. The protein 
samples were loaded with 1x or 5x protein loading dye then heated in a 95°C 
water bath for at least 5 minutes to denature the protein bands. The gel was run for 
Ahmed Helaly                                                                    Materials and Methods                                                                                                                                 
 
71 
 
75 minutes at 100 volts. The following step was to stain the gel with Coomassie or 
SYPRO Ruby stains. In some experiments, the gels were used for western blotting. 
 
2.3.2 Protein expression in E. coli 
Chemically competent transformed PL21DE3 and Arctic Express cells were 
incubated at 37°C for 24 hours on ampicillin-loaded plates as a method to select E. 
coli colonies that contain Prset Plasmid carrying the gene of interest. The colonies 
of interest were picked up and left to grow in LB broth loaded with 50 Pg/l 
ampicillin. The samples were incubated overnight at 37°C with strong shaking at 
220 per rpm. The following day, the growing bacteria were diluted by 10 to 100 
times in LB broth containing ampicillin, and left in the incubator with vigorous 
shaking for 2 hours. The subsequent step was to measure the OD of the growing 
bacteria containing the plasmid of expression at 600 nm wavelength; the optimum 
reading was 0.6. Control bacteria having the anti sense Prset plasmid were grown 
in the same way, and at the same time. After preparation, induction of the cells was 
started. 1mM IPTG (isopropyl-ȕ-D-1-thiogalactopyranoside) was loaded to the 
growing cells, with non-IPTG loaded cells as a control. The volume of the induced 
samples was expected to be 50 ml or more. If PL21DE3 cells were used, the 
induction time would be 3 hours in the incubator with vigorous shaking at 37°C or 
30°C in different experiments in 2 different shakers. On the other hand, Arctic 
Express cells were induced overnight at 12°C with vigorous shaking. 
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2.3.3 Protein extraction and analysis  
The samples and controls were removed from the incubators at the correct time, 3 
hours for PL21DE3 bacteria and 12 hours for Arctic Express Cells and the samples 
spun at 20,000ug for 10 minutes; the supernatant was discarded. The cells were re-
suspended in a smaller volume of Tris-NaCl Buffer (50mM Tris, 150mM sodium 
chloride). Generally, each 10 ml culture was re-suspended in 3 ml of buffer. 
However, if the amount of expressed protein is low, the sample could be re-
suspended in a smaller volume of buffer. Then, 1mg/ml lysozyme was added to the 
buffered cells to lyse the cell wall. The mixture was incubated at 27°C for 30 
minutes. The next step was to sonicate the samples to break the cells down. Large 
volume samples were sonicated for 5 minutes at 60% power for 50% of the time 
(the sonicator has a timer that produces the ultra sonic wave per time). The 
samples should be kept in ice as overheating would coagulate the targeted protein. 
To differentiate the soluble from non-soluble protein fraction, centrifugation at 
20,000ug for 30 minutes was applied, and the supernatant kept separate, while the 
pellet protein was kept as a control. To analyze the samples, 5x SDS protein 
loading dye was added to 20 Pl of the prepared protein either soluble or pellet. The 
samples were heated at more than 95°C for 5 minutes, then loaded onto acrylamide 
gel. Electrophoresis was run for 75 minutes at 100 volts with a suitable protein 
marker. The gel was stained with Coomassie stain for 45 minutes (0.25 g 
Coomassie R-250 mixed with 90% volume of methanol:water (1:1 v/v) and 10% 
glacial acetic acid, allowed to mix for one hour and filtered through Whatman 
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3MM paper), and destained later after 45 minutes with destaining solution (30% 
methanol and 10% glacial acetic acid in distilled water). Usually the gel was de-
stained multiple times every 20 minutes until the bands became clear. The gel was 
transferred to the gel dryer where it was dried for 1.5 hours. 
 
2.3.4 SYPRO Ruby dye for protein gel staining 
SYPRO Ruby is a very sensitive stain that is supposed to detect as little as 1 ng 
protein bands separated by electrophoresis. It was used as an alternative to 
Coomassie to detect small quantities of protein. Once electrophoresis was finished, 
the gel was immersed in 50 ml of SYPRO Ruby stain (the stain should kept away 
from light in a clean box covered with aluminium foil). The gel was kept in stain 
for at least 3 hours or overnight. In the following step, the gel was de-stained with 
solution containing 10% methanol and 7% glacial acetic acid for one hour. The gel 
was placed into the gel doc machine for direct transilluminating and 
photographing using the Versa Doc Imaging System Model 1000 from BIO-RAD. 
 
2.3.5 SDS-PAGE Gel Drying 
The gel taken from the BIO-RAD cassette after electrophoresis was covered by 
SARAN film and placed over wet Whatman 3MM paper. The gel was placed in a 
Model 583 Gel Dryer. The gel was put under vacuum at a temperature of 80°C for 
1.5 hours. 
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2.3.6  Protein purification by histidine-binding Nickel Column  
A 20 ml syringe was loaded with 10 ml His-binding resin from Novagen. 30 ml 
D.W. was used to wash ethanol from the resin. 50 ml 1x charge buffer (50 mM 
NiSO4) was loaded to charge the resin. D.W. was used to wash out excess NiSO4. 
30 ml 1x binding buffer (20mM sodium phosphate buffer, 500mM NaCl, 5mM 
imidazole) was loaded. The protein sample was loaded at a slow rate (0.25 
ml/min). After that, 50 ml of 1x binding buffer was added to remove unbound 
protein. In the next step, 50 ml 1x washing buffer (20mM sodium phosphate buffer, 
500mM NaCl, 30mM imidazole) was added to get rid of weakly attached protein. 
Finally, the protein was eluted by 30 ml 1x eluting buffer (20mM sodium phosphate 
buffer, 500mM NaCl, 500mM imidazole). 
 
2.3.7  Protein sequencing of CeAhR LBD band 
The expected soluble CeAhR LBD band was cut from the gel and put in an 
Eppendorf tube and sent for sequencing. The acetic acid percentage in the 
Coomassie stain and destain should not exceed 4%. The de-staining time should 
not be more than 45 minutes. 
 
2.3.8 Detection of the CeAhR LBD protein amount  
The soluble AhR protein was run on a gel against serial bovine serum albumin 
(BSA) dilutions. The amount of CeAhR LBD protein was determined by 
comparison of the thickness of the target band in relation to gradient BSA bands. 
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Calculations were performed to obtain the CeAhR LBD protein production per 
litre culture. 
 
2.3.9 Bradford assay 
This is a colorimetric method to quantify total protein samples. 5X Bradford dye 
was formed by dissolving 100 mg Serva blue-G250 in 50 ml 95% ethanol and 100 
ml 85% phosphoric acid. De ionized water was added to make the volume of the 
solution to 1 litre. Serial dilutions of BSA from 0 to 100 Pg/ml were freshly 
prepared from stock solution. To prepare 1X Bradford dye, the 5X dye was diluted 
in distilled water and filtered through Whatman filter paper. 1 ml fresh dye was 
added to each of the serial BSA protein concentrations in 20µl volume. Then the 
sample was vortexed and left for less than 5 minutes at room temperature creating 
a spectro-photometric standard curve. The sample absorbance was measured at 
595 nm. The unknown samples were compared to the standard curve to calculate 
the concentration of the target samples. 
 
2.3.10 Dot Blot Protocol  
This is an antigen-antibody technique to detect proteins. It works on the same 
principles as Western blotting but without electrophoresis. The protein was 
identified in situ as a circular spot. The Dot Blot could be used in a semi-
quantitative way to evaluate the amount of expressed protein. To perform a Dot 
Blot, a small strip (1x4 cm) of nitrocellulose membrane was cut. A grid (5mm) was 
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marked out with a pencil, where blotting was applied. 2 Pl of the protein sample 
was dropped in the centre of the grid. The membrane was left to dry for 5 minutes. 
Then, the membrane was blocked for non-specific binding sites by 5% BSA in 
TBS then incubated with anti His tag (0.5 µg/ml) or anti GST HRP conjugate (0.5 
µg/ml) for 45 minutes. The following step was to wash the membrane with TBS-T 
(Tween TBS) 5 times for 5 minutes each time. Finally, the membrane was 
incubated with ECL reagent (the kit containing the chemiluminescent substance 
transformed into a light and heat producing product) for 1 minute in the gel doc 
machine, and the florescence of the protein was detected by the gel doc camera. 
 
2.3.11 Western blot  
The protein sample was run by SDS-PAGE gel as mentioned before. Following 
that, the protein was transferred or blotted to the nitro cellulose membrane. The 
nitro cellulose membrane was placed on top of the gel then this was sandwiched 
between 2 pieces of 3MM Whatman paper. The layers were kept as follows: 1- the 
black edge of the cassette down. 2- One layer of 3MM Whatman paper. 3- The gel. 
4- The nitrocellulose membrane. 5- One layer of 3MM Whatman paper. 6- The 
edge of the cassette. The cassette was put under gentle pressure to remove the air 
bubbles. This sandwich could be set up under water to remove any air bubbles. 
The cassette was placed into a Bio Rad tank that was filled with 1X transfer buffer 
(36g tris, 150g glycine , 4g SDS in 1L distilled water) . The electric current was 
applied for 1 hour at 90 volts. 
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After finishing the blotting, the nitrocellulose membrane was moved to a container 
and blocked with 5% BSA-TBS blocking solution overnight. The following day, 
the nitrocellulose membrane was incubated with either anti- His HRP tag or anti-
GST HRP for 45 minutes with a dilution of 1:10,000 in 5% TBS-T as was done in 
dot blotting. Then, the nitrocellulose was washed with TBS-T for 5 minutes 5 
times. The following step was adding ECL to the nitro cellulose membrane in the 
gel doc machine. Finally, the machine was closed to detect the fluorescence 
reflecting the bands of the target protein. 
 
2.4 Yeast techniques 
2.4.1 Sub-cloning of GST tagged CeAhR LBD into pPD30.38 
The GST CeAhR LBD was lifted from PET41b by double digestion with both 
Xba1 and Sac1. The CeAhR LBD was inserted into the pPD30.38 vector that was 
double digested by Nhe1 and Sac1. In order to prevent methylation of DNA that 
interferes with restriction digestion by Xba1, the plasmid of interest was 
transformed in SCS E. coli 110. Then the samples were mini-prepped. The DNA 
was purified and cut with Sac1 and Xba1. The sub-cloning was performed by 
lifting the CeAhR LBD DNA fragment from the PET41b vector and inserting it 
into pPD30.38i. The GST CeAhR LBD is 1529bp; 480 amino acids and the 
expected protein size is about 54 kDa. The expected expressed His tagged CeAhR 
LBD lifted from Prset is supposed to be 29 kDa, and about 600 bp. The sub-cloned 
constructs were sequenced using both 385 primers (Table 2). 
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2.4.2 Cloning into pPICZ alpha B and pPICZ B  
GST CeAhR LBD was lifted from PET41b and sub-cloned into both pPICZ B and 
pPICZ alpha B in a similar way as that sub-cloned in pPD30.38, except that GST 
CeAhR LBD in PET41b was double digested with Ecor1 and Xba1 and sub-cloned 
into both pPICZ alpha B and pPICZ B after double digesting the vectors with the 
same restriction digestion enzymes. 
 
2.4.3 PCR of CeAhR LBD with new restriction digestion sites carrying both 
Ecor1 and Xba1. 
PCR primers 3 and 4 (Table 2) were used to clone CeAhR LBD from the pRSET 
Plasmid to be sub-cloned into the PGEMT vector.  
The PCR reaction mixture consisted of: 
1- 30 Pl PCR master mix. 
2- 1ul each of primers (3, 4)  
3- 1 Pl DNA (pRSET/CeAhR LBD) at different dilutions 
The setup for the PCR program was: 
1- 94°C for 30 seconds 
2- Annealing temperature: 60°C for 20 seconds 
3- Extension temperature: 72°C for 1 minute. 
4- Melting temperature: 94°C for 15 seconds. 
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2.4.4 Sub cloning of CeAhR LBD into pGEMT plasmid 
The CeAhR LBD ligation reaction was setup in pGEMT vector. The reaction was 
formed of 10 Pl volume, which contained 1Pl ligase, 2Pl insert, 2 Pl vector and 
5Pl 2x Buffer. As before, various insert:vector ratios were used. The ligated DNA 
samples were then transformed into JM109 cells by electroporation.  Different 
controls were set up according to the Promega manual. The reaction was also 
performed with just cells as a negative control, as well as a transformation 
efficiency control, a background control and a new positive control represented by 
the control insert, i.e. blue/white colony selection. The white colonies were 
supposed to have the ligation constructs. The blue white selection depends on the 
basis that non construct containing colonies are able to metabolize the substrate on 
the plate giving the blue colour, however, successfully cloned bacteria contain 
plasmids that are interrupted by the constructs and therefore not able to metabolize 
the substrate to produce colour giving white colonies. The ligation reaction was 
deemed to be successful if the white colonies represented more than 60% of all 
colonies. As such 6 white colonies were picked up and mini-prepped to detect the 
CeAhR LBD insert.  
 
2.4.5 Sub cloning of CeAhR LBD from pGEMT into pPICZ alpha B and 
pPICZ B 
 The CeAhR LBD PCR product, which has both EcoR1 and Xba1 sites, was 
cloned in PGEMT. Then, the CeAhR LBD pGEMT construct was double digested 
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with both EcoR1 and Xba1. The AhR was re-sub-cloned in both pPICZ alpha B 
and pPICZ B using the same method of cloning using electroporation. The 
suspected transformed colonies were mini-prepped and double digested again with 
EcoR1 and Xba1 again to detect CeAhR LBD inserts. So, after multiple sub-
cloning CeAhR LBD and GST CeAhR LBD were sub-cloned into both pPICZ B 
and pPICZ alpha B. In order to check the integrity of the 4 prepared constructs 
they were sequenced using AOX1 forward primer.  
 
2.5 Electroporation of Pichia  
Electroporation is a very good method for isolating multi-copy clones. The first 
step was growing 5 ml Pichia pastoris GS 115 in a 50 ml conical falcon tube at 28 
to 30°C. The following day, this culture was added to 500 ml YPD media (10g 
yeast extract, 20g peptone and 20g dextrose dissolved in 1 L distilled water and 
autoclaved for 20 minutes) in a 2 litre flask, and incubated overnight until the OD 
at 600 nm was up to 2. The cells were spun at 1500ug at 4°C for 5 minutes then re-
suspended in 0.5 litre ice-cold water. The samples were spun again in the same 
way, and again re-suspended in 0.25 litre ice-cold water. The samples were 
centrifuged for a third time and re-suspended in 20 ml of ice cold 1M sorbitol. The 
samples were spun again for the last time, and re-suspended in 1.5 ml ice-cold 1M 
sorbitol. The cells were kept in ice for electroporation. The cells should be 
subjected to electroporation on the same day, as freezing cannot keep the cells 
competent.  
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80 Pl of the cells were prepared using the above method, and incubated with the 
ethanol-precipitated linearised target DNA (pPICZ alpha B, pPICZ B carrying 
CeAhR LBD). The DNA was linearised by digestion with Sac1 restriction 
digestion enzyme. The mixture was kept in a cuvette in ice for 5 minutes. The 
Pichia was pulsed at a voltage of 2 kV. The cells were immediately rescued with 
1ml ice-cold 1M sorbitol, and transferred to a sterile 15 ml tube. The tube was 
incubated at 30°C in the incubator without shaking. The next step was plating each 
100 Pl of cells on individual YPDS Agar plates (10g yeast extract, 182.2g sorbitol, 
20g peptone and 20g agar in 0.9 L D.W; 100 ml of  filter sterilized 20% Dextrose 
was added to complete the total volume to 1 L) loaded with 100 Pg/ml Zeoicin 
after cooling the fluid to 60°C. The plates were left in the incubator for 2-4 days 
waiting for the colonies to reform.  
 
2.5.1 Yeast Genomic DNA Extraction 
A yeast colony was picked and grown as a 1.5 ml liquid culture overnight at 30°C 
in YPD media (10g yeast extract, 20g peptone and 20g dextrose dissolved in 1L 
D.W. and autoclaved). The following day, the cells were spun at 20,000ug for 5 
minutes, and then 200 Pl lysis Buffer (2 ml Triton X -100, 5ml 20% SDS, 2 ml 5M 
NaCl, 2 ml 1M tris-HCl pH 8, and 2ml of 0.5M EDTA made up to 100ml with 
distilled water) was added. The tube was dropped in liquid nitrogen for 2 minutes, 
then transferred into a 95°C water bath for 1 minute. This step was repeated and 
the sample vortexed for 30 seconds. Then 200 Pl chloroform was added and the 
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sample was vortexed for 2 minutes. The sample was centrifuged at 20,000ug at 
room temperature for 3 minutes. The upper aqueous phase was transferred to an 
Eppendorf tube carrying 400 Pl ice-cold 100% ethanol. The sample was mixed by 
inversion, incubated at room temperature for 5 minutes, then centrifuged at room 
temperature for 5 minutes at 20,000ug and the supernatant removed with a pipette. 
The pellet was washed out with 0.5 ml 70% ethanol. The sample was centrifuged 
again, and the supernatant was removed. The pellet was air dried for 5 minutes, re-
suspended in 10 Pl water and the concentration determined (Figure 16).  
 
Figure 16. Spectrophotometric curve of DNA (genomic DNA extracted from Pichia pastoris) 
using the Nano Drop machine. The figure shows a graph of the absorbance of DNA sample 
against wavelength. The software converts the absorbance into DNA concentration (ng/Pl). 
The calculation is based on the equation that 50 ng double stranded DNA gives 1 absorbance 
unit at 260 nm. The volume of DNA sample is 1µL.  
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2.5.2 Analysis of Pichia colonies by PCR 
To set up the PCR reaction, Pichia genomic DNA was extracted and used as a 
template for the PCR reaction.  
The PCR reaction was set up, with the following required: 
1- PCR simple Master Mix, 27 Pl. 
2- AOX1 forward primer (10pmol/Pl) 
3- AOX1 reverse primer (10 pmol/Pl) 
       Both primers were mixed and 1µl of the mixture used in each reaction 
4- Extracted Pichia genomic DNA, 1 Pl containing 0.5 to 1 µg DNA. 
 The mixture was placed in the PCR machine and the program was set up as 
follows: 
1- Incubation at 94°C for 2 minutes 
2- Denaturation at 94°C for 1 minute 
3- Annealing at 54°C for 1 minute 
4- Extension at 72°C for 1 minute  
5- Final extension at 72°C for 7 minutes.  
 
2.5.3 Hot Phenol Yeast total RNA Extraction 
This method could be used to extract RNA from 10 ml yeast culture. The cells 
were collected and centrifuged, and the pellet snap-frozen and stored at –80°C. 
This method is expected to yield up to 500 Pg RNA. The pellet was then collected 
and re-suspended in 400 Pl AE Buffer (50 mM sodium acetate and 10mM EDTA), 
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then 40 Pl 10% SDS was added and the mixture vortexed for 20 seconds. 500 Pl 
phenol was added and the mixture vortexed again for 20 seconds. The mixture was 
then taken and put in a water bath at 65°C for 4 minutes, after which it was 
dropped in liquid nitrogen for less than a minute to form crystals. The mixture was 
thawed then vortexed and the samples were refrozen in liquid nitrogen. The 
sample was thawed and spun at 4°C for 10 minutes at 20,000ug. The aqueous 
component was transferred to a fresh tube. An equal volume of phenol was added 
and the mixture vortexed for 20 seconds and spun at 4°C at the maximum speed 
(20,000ug) for 10 minutes. The aqueous component, whose volume was about 400 
Pl, was transferred to another fresh tube. 0.1u volume of sodium acetate pH 5 and 
2.5u volume of 100% ethanol were added. The mixture was incubated at -20°C for 
at least one hour, or even better overnight. Following incubation, the sample was 
spun at the maximum speed (20,000ug) for 20 minutes and the pellet was washed 
with 0.5 ml 70% ethanol that was prepared by adding DEPC water to 100% 
ethanol. The following step was re-suspending the pellet in 200 Pl DEPC water 
and then the RNA concentration was measured on the Nano drop machine and 
stored at –80°C.  
 
2.5.4 RNA Electrophoresis Gel 
1% agarose was prepared as mentioned before in section 2.2.1.5. After melting the 
gel, 1ml 1% SDS was added to the solution, which was poured in the cassette. The 
RNA was loaded with 10X RNA loading dye. The samples were run by 
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electrophoresis for one hour at 70 volts. A DNA ladder was run beside the sample, 
but in consideration that RNA is single stranded and DNA is double the size of 
RNA.  
 
2.5.5 RNA to cDNA reverse transcription 
This RNA to cDNA kit contains all Buffers and materials required for reverse 
transcription of total RNA into single stranded DNA in a 20 Pl volume reaction. To 
achieve success in this experiment, the RNA was cleaned and freed from RNase 
activity. 10 Pl 2X RT Buffer were added to 1Pl 20X RT Enzyme Mix and made up 
to 20 Pl by adding RNase free water. The sample was mixed well and put in a 
suitable PCR tube. The tube should not contain any air bubbles, and if so, the 
sample spun down to remove these air bubbles. The thermal cycler program was 
set for 3 steps. The first step was 37°C for 60 minutes, the next step was 85°C for 
5 minutes and finally the sample was kept at 4°C until it was collected. 
 
2.6 C. elegans Techniques 
2.6.1 Sub-cloning of CeAhR LBD into pPD30.38 
The first step was double digesting pPD30.38 with SaC1 and Nhe1 restriction 
enzymes. The success of double digestion was confirmed by running an agarose 
gel with uncut pPD30.38 as a control, and the single digested pPD30.38 as the 
other control. At the same time, the CeAhR LBD was lifted from the pRSETb 
plasmid by double digestion with Xba1 and Sac1 enzymes, and the fragment 
Ahmed Helaly                                                                    Materials and Methods                                                                                                                                 
 
86 
 
inserted in the cut pPD30.38. The insert to vector ratio should be at least 3:1 for a 
successful ligation reaction. DNA gel electrophoresis of the CeAhR LBD insert 
and flanked pPD30.38 vector was run at 80 volts for 45 minutes with a suitable 
DNA ladder (1 Kb +). It was better to post-stain the gel with ethidium bromide 
keeping the background of the gel clear. The following step involved visualising 
the DNA bands in the dark reader, where the CeAhR LBD band was cut with a 
clean razor, and at the same time the flanked pPD30.38 was also cut, and both gel 
fragments put in clean Eppendorf tubes.  
 
2.6.2 Maintenance of the C. elegans worms 
C. elegans were maintained on lawns of OP50 E. coli growing on NGM agar 
plates. The bacteria (200 µl volume) were plated on the NGM agar poured in petri 
dishes (9 cm) and left in the incubator at 37°C for 24 to 48 hours. Once the C. 
elegans had multiplied and exhausted the bacterial food supply it was necessary to 
passage them to a new plate. They were transferred from the old plate by 
“chunking” whereby a piece of agar carrying at least 5 animals was cut out and 
transferred to the new plate. The cutting of the agar was performed with a sterile 
scalpel. To make the scalpel sterile, it was heat flamed with alcohol. To prepare 
NGM plates, 3g NaCl, 17g agar, and 2.5g peptone were added to 800 ml D.W. and 
autoclaved for 25 minutes. The NGM agar was left in a 60°C water bath. 300 µl of 
each of 1M CaCl2 and 1M MgSO4, 25 ml K phosphate buffer (250 ml 1M 
KH2PO4/200 ml 1M K2HPO4) and 5 g Cholesterol were added to NGM agar 
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solution in the water bath. The agar complex was poured into 9 cm plates and left 
to set. 
 
2.6.3 Preparation of C. elegans Liquid Culture 
On day one, OP50 Bacteria were grown overnight in 1 litre LB broth. 5 ml of 
already grown bacteria were inoculated into the entire 1 litre of LB. On the 
following day, the growing bacteria were centrifuged at 2000ug for 20 minutes. At 
the same time, 1 litre of S media was prepared by adding 2 ml Cholesterol (5g/ml), 
2 ml of potassium citrate buffer (20g citric acid monohydrate, 293.5g Tri-
potassium citrate, and D.W. up to 1L.), 300 Pl 1M CaCl2, 300 Pl 1M MgSO4 and 
0.5 ml trace elements (1.86g disodium EDTA, 0.69g FeSO4.7H2O, 0.2g 
MnCL2.2.4 H2O, 0.29g ZnSO4.7 H2O, 0.025g CuSO4.5 H2O and H2O to 1L.) to 1 
litre S-Basal (5.84g NaCl, 43.4ml 1M KH2PO4, 6.6ml 1M K2HPO4, to 1 litre with 
water and autoclaved). The bacterial pellet was added to about 500 ml S-Media 
and the OD measured at 600 nm taken. The OD should be 1.7 giving indication 
that the bacterial food is enough for the liquid culture to grow the animals for up to 
6 days. Finally, an NGM plate carrying C. elegans worms growing for 2-4 days to 
give a large number (thousands) that is expectected to grow to millions in the 
liquid culture was washed with S-Basal, added to the flask containing the S-
medium/OP50 mixture and incubated at 20°C with shaking at 200 rpm. The flask 
was left in that environment for 3-6 days. 
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2.6.4 Egg bleach to produce synchronized animal stages for lethality test 
The worms, grown from the liquid culture, were left to settle in the bottom of a 
500 ml bottle, and left for 1 hour in ice. Once the worms collected in the bottom of 
the bottle, the excess medium was removed carefully from the worm surface. The 
worms were collected in a 50 ml falcon tube. The same volume of bleach as the 
volume of the worms was added and continuously mixed for 4 minutes. The 
sample was centrifuged in a horizontal centrifuge at 500ug for one minute. The 
eggs and debris were collected in the bottom of the tube. Rapidly and carefully, the 
extra fluid was removed by a syringe and replaced by S-basal and the sample 
mixed and re-centrifuged. This was considered one wash. The wash was repeated 
4-5 times to remove the remnants of the bleach that could kill the eggs. After the 
final wash, the sample was mixed in 5 ml of S-Basal and the sample was separated 
into a 6 well plate, and left overnight so that the eggs hatch into larvae. The 
animals were spread on new NGM plates and incubated in a 15°C incubator for 3 
days before use in the lethality test. 
 
2.6.5 Lethality test for AhR different agonists 
The NGM plates carrying uniform L4 N2 C. elegans were washed with S-Basal 
and the animals collected in a 20 ml flask. The supernatant was taken off leaving 
the worms in a volume of 5 ml at most. OP50 bacteria were collected and spun 
down, and then re-suspended with S-Basal at OD of 0.7 at 600 nm wavelength. 
The following was added to each well of a 6 well plate: 900 Pl S-Basal, 50 worms, 
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1Pl test compound dissolved in DMSO (Table 5) and 100 Pl bacteria. Six different 
chemicals were examined by lethality tests (see Table 5). 
Table 4. The chemical concentrations used in the lethality tests. The chemicals were dissolved 
in DMSO and 1µl of the solution was taken and diluted in 1ml volume of fluid containing the 
animals. 
Compound Stock in DMSO Range used in dose-
response experiment 
TCDD 1 mM 1nM  - 1 µM 
AZ1c
 
1 µM 1 pM - 1 nM 
PCB 126 10 mM 10 nM - 10 µM 
3MC 20 mM 20 nM - 20 µM 
2-(4-amino-3-methylphenyl) 
benzothiazole 100 µM 100 pM - 100 nM 
ȕ-naphthoflavone 300 mM 300 nM - 300 µM 
 
 The samples were mixed and the 6 well plate covered by paraffin film and put in a 
humid box that was closed. Finally, the box was moved to a 15°C incubator for 3 
days. The animals were checked every day for 3 days, and after this, the lethality 
of target toxins was evaluated. The maximum final concentration was diluted 10 
fold for 3 times to create a dose response curve. For example, TCDD 
concentrations used in the lethality test were 1µM, 0.1 µM, 0.01µM and 0.001µM. 
 
2.6.6 Making Protein Gel Samples from Worms 
Up to five 9cm plates of worms were grown for 6 days. This was expected to give 
~200 µl of packed worms after the washes. The worms were washed off the plates 
by adding 1ml S- Basal medium on the plate, swirling gently, and the liquid 
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sucked off with a Pasteur pipette. The worms were spun by centrifugation to pellet 
the worms, and the supernatant was discarded. The worms were washed once with 
S-Basal, spun down and the supernatant discarded. The worms were transferred 
into a small amount of S-Basal in an Eppendorf tube, and centrifuged for a short 
period at 3,000 rpm, and as much liquid as possible removed. At that point, the 
worms were frozen at -80°C. Then 1 ml gel sample buffer (50mM Tris-HCl pH 
6.8, 2% SDS, 10% glycerol, 1% beta-mercaptoethanol, 12.5mM EDTA and 0.02% 
bromophenol blue) was added and boiled in the tube (a screw cap Eppendorf was 
used) for 5 minutes, then the tube was centrifuged for 10 min to pellet the debris 
and the supernatant transferred to a new tube. Boiling was expected to break the 
body wall of the adults; sonication for 20 seconds was applied using a Branson 
sonifier with a probe sonicator having a microtip. The machine was set up at the 
microtip limit, on a 2 second 50% cycle. Once sonication was achieved correctly, 
no frothing was detected. By examination of the tube under the dissecting 
microscope, almost no worms or debris were visible. The tube was centrifuged for 
10 min to pellet the debris and the supernatant transferred to a 1 ml screw cap 
tube. The samples were run by SDS PAGE gel and stained with Coomassie stain. 
 
2.6.7 Measuring the fluorescence of GFP-CYP fused C. elegans  
The transgenic C. elegans containing GFP-CYP fused enzymes were tested with 
TCDD, AZ1c, 3MC, PCB 126 and 2-(4-amino-3-methylphenyl) benzothiazole to 
detect induction of CYP35A2, CYP29A2 or CYP34A9 enzymes that are 
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conjugated with GFP protein. These CYP enzymes are known to be induced by the 
xenobiotic response in C. elegans (Menzel et al., 2001). The samples were loaded 
onto a plate reader and a WALLAC 1420 VICTOR2 was used to measure the 
amount of the fluorescence in each sample or control. The cocktail samples of 
animals with added toxins were collected after 3 days of lethality testing. 300µl is 
the maximum capacity of the each well of a 96 well dark reader plate. The animals 
were collected from the bottom of the well of the six well plate as used in lethality 
tests. The samples were transferred to the dark plate with the negative control 
samples. The plate was placed in the dark reader and the software would read the 
fluorescence emitted from each plate 4 times. The samples were compared to the 
controls and the Data were collected in an excel spreadsheet.  
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3 RESULTS 
 
3.1 Expression of CeAhR LBD protein in E. coli 
The CeAhR LBD has been successfully cloned by Dr David Bell in Prset plasmid 
ZLWK%DP+ǿVLWHVThe first approach was to try and express this DNA in E coli. 
Successful expression would yield CeAhR LBD protein of about 29 kDa with a 
poly histidine tag that would help purification later on.  
Experiments to express His-tagged CeAhR LBD protein in E. coli BL21(DE3) 
cells were performed. BL21(DE3) cells were transformed with pRSET plasmid 
containing His-tagged CeAhR LBD, and with an identical plasmid containing 
CeAhR LBD in the anti-sense orientiation as a negative control. The cells were 
induced by IPTG and incubated for 3 hours at 37°C in the shaker and total protein 
samples isolated. The SDS-PAGE results (Figure 1) showed that cells transformed 
with both sense and anti-sense express similar protein bands, except for thick 
protein bands in the sense samples of about 29 kDa. This band corresponds to the 
expected size (CeAhR LBD) is 200 amino acids which is 29 kDa, of the predicted 
protein for the His-tagged CeAhR LBD.  
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29 kDa
 
Figure 17. SDS-PAGE gel of total bacterial extracts. BL21(DE3) bacteria were transformed 
with pRSET plasmid containing the AhR LBD in anti-sense (A) or sense (S) orientation. Cells 
were induced for three hours with IPTG at 37°C, and total protein isolated. The samples 
consist of 10 µl of PL21(DE3) cells transformed with anti-sense histidine-tagged CeAhR LBD 
(A) or sense histidine-tagged CeAhR LBD (S1,2). Each 10 µl sample was mixed 1 in 10 with 
load buffer prior to heating and running in each lane respectively. L is the ladder that consists 
of 5µl of suitable protein marker. 
 
3.2 Expression of CeAhR LBD soluble protein component 
After successful expression of CeAhR LBD in E. coli, experiments were carried 
out to determine if it is possible to obtain CeAhR LBD protein in a soluble form. 
Induction of CeAhR LBD by transforming BL21(DE3) was performed as 
described before. First, sonication of the protein samples was carried out, then 
centrifugation at 20,000xg, after which the supernatant was analysed. Both 
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pelleted and soluble samples were loaded on an SDS-PAGE gel. Figure 18 shows 
thick protein bands at about 29 kDa in the pellet samples (P1&2) and faint similar 
bands in the soluble samples (S1-4) showing that most of the expressed protein is 
insoluble.  
29 kDa
 
Figure 18. Solubility of AhR LBD in bacterial extracts; BL21(DE3) were transformed with 
pRSET plasmid containing sense CeAhR LBD, then induced with IPTG at 25°C or 30°C for 3 
hours. Bacteria were lysed and the samples centrifuged at 20,000xg for ten minutes. The 
supernatant comprised soluble protein samples induced at 25°C (S1,3) or induced at 30°C 
(S2,4). The pelleted fractions (P1,2) were the non-soluble proteins induced at 25°C or 30°C 
respectively. Each 10 µl sample was mixed 1 in 10 with load buffer prior to heating and run in 
each lane as indicated. L is the ladder that consists of 5µl of suitable protein marker. SDS-
PAGE was performed as described in the Materials and Methods. 
 
Figure 18 shows that most of the expressed protein was insoluble. The soluble 
fraction was little. Lowering the temperature of expression produced more soluble 
protein as in sample S3. The soluble protein was separated from the pellet by ultra 
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filteration. Given that the 29kDa band in the soluble fraction was relatively faint, it 
was essential to confirm the identity of this protein. Its identity was confirmed by 
tryptic digest and sequencing of the protein band in the soluble sense lane. The 
results of this study showed that there is structural identity with CeAhR LBD in 
the sequence of 12 peptides, thereby proving that CeAhR LBD is present in the 
soluble fraction (Table 5). 
 
Table 5. The amino acid sequence of the CeAhR LBD and highlighted in red (below) are 12 
peptides sequenced from the protein bands following their tryptic digestion. Each peptide is 
identical to a portion of the CeAhR LBD. 
 
MRGMRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPGFLRIDMRGKLMSLHGLPSSYVMGRTASGPVLG 
       HHHHHH     TGGQQMGRDLYDDDDKDPGFLR 
 
MICVCTPFVPPSTSDLASEDMILKTKHQLDGALVSMDQKVYEMLEIDETDLPMPLYNLVHVEDAVCMAE 
                          HQLDGALVSMDQK 
 
AHKEAIKNGSSGLLVYRLVSTKTRRTYFVQSSCRMFYKNSKPESIGLTHRLINEVEGTMLLEKRSTLKA 
                         TYFVQSSCR    NSKPESIGLTHRLINEVEGTMLLEK 
 
KLLSFDDSFLQSPRNLQSTAALPL 
  LSFDDSFLQSPR 
 
 
3.3 Expression of CeAhR LBD protein in Arctic Express cells at lower 
temperature 
Arctic Express cells enable induction of target proteins at the lower temperature of 
12°C, and additionally over-express a chaperone system; it was decided to 
determine whether these factors would enhance the expression of soluble CeAhR 
LBD. Arctic express cells were transformed and induced by IPTG using the same 
procedure as described before for BL21(DE3) cells. Figure 19 shows a thick band 
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at 29 kDa as the only difference between sense and anti-sense samples, 
demonstrating successful CeAhR LBD induction. The antisense band was found to 
be an endogenous protein of the same size as CeAhR LBD. Protein sequencing 
confirmed the presence of both CeAhR LBD and the endogenous protein. The 
protein bands can be seen in Figure 19.  
29kDa
 
Figure 19. SDS-PAGE gel for Arctic Express cells transformed with sense (S1-3) or antisense 
(A1-3) His-tagged CeAhR LBD and induced by IPTG at 12°C. Each 10 ml sample was mixed 
1 in 10 with load buffer prior to sampling in each lane respectively. L is the ladder consisting 
of 1 in 6 protein marker. SDS-PAGE was performed as described in the Materials and 
Methods.  
 
A1       A2          A3         L         S1           S2         S3 
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3.4 Comparison between expressed BL21(DE3) and Arctic Express 
transformed cells with histidine-tagged CeAhR LBD 
Experiments were performed to compare and measure the amount of soluble 
29kDa expressed protein after purification on a nickel column. The soluble 
components expressed by the cells, either BL21(DE3) or Arctic Express, were 
centrifuged at 250,000xg for thirty minutes to ensure that the samples contain 
soluble protein. Next, the soluble samples were purified by affinity 
chromatography on a nickel column. The eluted and wash samples of both 
BL21(DE3) and Arctic Express cells were compared to various amounts of BSA 
(1, 2, 4, 5 and 10 µg). The results revealed that both cells expressed less than 1µg 
of soluble CeAhR LBD protein in wash samples (Figure 20). Furthermore, the 
Arctic Express results (W1, W2) were better than those of BL21(DE3) cells (W). It 
was possible to calculate the amount of soluble protein from a known volume of 
culture. W1 and W2 are 2% of the soluble CeAhR LBD from 450 ml of bacterial 
culture; thus estimating a yield of ~0.1 mg per litre of culture. Therefore, the 
amount of CeAhR LBD is approximately 1 mg per 10 litres of culture, which is 
inadequate for crystallization experiments. 
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Figure 20. SDS-PAGE gel of affinity-purified samples. CeAhR LBD was induced in 
BL21(DE3) (W) or Arctic Express (W1, W2) cells and the soluble fraction isolated by 
sequential centrifugation at 2000xg for 10 minutes and 250,000xg for 30 minutes. Samples 
were then purified on a nickel affinity column and eluted samples are shown. 1, 2, 4, 5 and 10 
are BSA samples of 1, 2, 4, 5 and 10 µg. L is ladder consisting of 3 µg of 1 in 6 protein marker. 
Each sample was loaded with 1 mg protein loading dye before sampling in each lane. SDS-
PAGE was performed as described in the Materials and Methods. 
 
3.5 Expression of CeAhR LBD in C. elegans 
The expression of CeAhR LBD in bacteria was successful but most of the 
expressed protein was insoluble and unsuitable for crystal structure work. We need 
a large volume (20 litres) of culture to purify just 1 mg of soluble protein. The next 
step was to try and express CeAhR LBD in higher eukaryotic system. The C. 
elegans itself was chosen to express its own protein hoping that it has all the 
chaperones needed to fold CeAhR LBD.  
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Three constructs were prepared for expression of CeAhR LBD in C. elegans, 
namely pPD30.38 CeAhR LBD His tag, pPD30.38 CeAhR LBD GST and 
pPD30.38 GST (negative control). Microinjection of these constructs was 
performed by Declan Brady. The constructs were injected with M cherry as a 
fluorescent marker indicating successful microinjection and creation of transgenic 
animals. Good expression of the control GST pPD30.38 was obtained; however, 
the expression of both CeAhR LBD constructs was negative with good expression 
of the control M Cherry. The protein production was checked by western blot, but 
no protein band of appropriate size was found, indicating failure of the expression 
system. The transgenic animals’ genomic DNA was extracted, and the existence of 
the constructs confirmed. The transgenic CeAhR LBD carrying animals were lysed 
and the genomic DNA was extracted. Suitable primers (primers 385 forward and 
reverse) were used to amplify the CeAhR LBD from the genomic DNA extracted 
from the transgenic C. elegans. The amplified DNA was run on 1% agarose gel 
and both His and GST tagged CeAhR LBD were confirmed before starting protein 
expression to avoid false negative results. 
 
3.6 Expression of histidine tagged CeAhR LBD in transgenic C. elegans 
After successful cloning of CeAhR LBD in transgenic C. elegans, experiments 
were performed to determine if it was possible to obtain CeAhR LBD protein, 
especially in soluble form. The protein samples were sonicated and centrifuged at 
500xg. Samples were loaded on an SDS-PAGE gel. The results showed no 
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significant CeAhR LBD band at the expected 29 kDa, suggesting no or weak 
expression (Figure 21). 
  
 
Figure 21. Commassie-stained protein gel of CeAhR LBD protein extracted from transgenic 
C. elegans. The animals were microinjected with His-tagged CeAhR LBD (left lane) or with 
M cherry (middle lane labelled “cherry”).  M is protein marker.  
 
The samples showed expressed proteins from both M cherry and CeAhR LBD 
microinjected animals. There were no expression bands different from the control 
for CeAhR LBD samples. These results indicated weak or no expression of 
CeAhR LBD in transgenic animals. The expression of M cherry was fine. To 
compare both samples to each other, the M cherry band does not exsist in the 
CeAhR LBD sample and the CeAhR LBD band does not appear in the M cherry 
sample. By estimating the expected bands from the size marker, it could be 
possible to confirm the expression of the M cherry but there was no evidence for 
His-tagged CeAhR LBD. Co microinjection of M cherry and CeAhR LBD aimed 
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to create transgenic animals expressing CeAhR LBD; M cherry gave red 
florescence that helped selection of the transgenic strains for expression. 
3.7 Expression of GST tagged CeAhR LBD in transgenic C. elegans 
GST CeAhR LBD was successfully microinjected in C. elegans and the transgenic 
animals were crushed to detect CeAhR LBD protein. The experiment was carried 
out with pPD30.38 GST as a positive control indicating the integrity of the system. 
Normal C. elegans animals were crushed and their protein used as negative 
control. The experiment showed a clear GST band (Figure 22), but unfortunately, 
no GST CeAhR LBD protein band was detected raising questions regarding the 
practicality of using this system for expression of CeAhR LBD.  
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Figure 22. Protein gel stained with Commassie stain. M is protein molecular weight marker. 
GST AhR is the GST tagged CeAhR LBD sample. Hist AhR is the His tagged CeAhR LBD 
sample. GST is the sample with the expressed GST tag only. The negative control is 
uninjected C. elegans. The black line shows the GST band (of 35 kDa in the GST-pPD30.38 
lane that is not in the negative control lane indicating succesful expression of GST) as a 
control indicating transgenic C. elegans working as expression system. 
 
Figure 22 shows proteins expressed from both GST CeAhR LBD and His tagged 
CeAhR LBD constructs. The experimental design included a negative control, 
which comprises the protein extracts from uninjected C. elegans. On the other 
hand, C. elegans carrying GST pPD30.38 is another control that proves the 
integrity of the transgenic C. elegans worms in expressing recombinant foreign 
protein. From Figure 22, the GST band was seen in contrast with the negative 
control sample. Yet, no recombinant CeAhR LBD bands at 29kDa (His-tagged 
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CeAhR LBD) or 54 kDa (GST-tagged CeAhR LBD) were detected. The system 
was not expressing CeAhR LBD or expresses it at a very low level. The following 
step was to perform western blot, which could detect protein bands down to 1 ng.  
 
3.8 Western blot of expression of CeAhR LBD 
Commassie stained protein gel can detect down to 100 ng protein bands. To 
evaluate the expression of CeAhR LBD at a lower scale, a western blot was 
performed on the gel samples run by electrophoresis. Figure 23 shows His tagged 
CeAhR LBD expression for comparison with negative control. From the gel, it is 
difficult to detect the clear band of CeAhR LBD protein. The western blot was 
repeated many times, yet the possible CeAhR LBD band was inconsistent; the 
expression trials were repeated 4 times with similar results. In Figure 23, a band 
can be seen in the CeAhR LBD lane that is different from the control. However, 
the antibodies were not specific enough to detect the His tag only. It gave results 
similar to the protein gel stained with Commassie, and again it was difficult to 
confirm expression of CeAhR LBD. The system was not practical for expressing a 
large enough amount of protein for crystal structure work.  
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Figure 23. Western blot of proteins extracted from transgenic C. elegans carrying His tagged 
CeAhR LBD constructs on the left. The lane lying in the middle showed the expressed protein 
of transgenic C. elegans microinjected with M cherry. The lane on the right side is that of the 
marker. The black line indicates the possible expressed CeAhR LBD band.  
 
The western blot of CeAhR LBD samples in Figure 23 showed multiple bands 
binding to the anti histidine antibodies. These results could be explained by excess 
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antibody loading or by less specificity against transgenic C. elegans proteins. The 
marker did not appear. By comparison between both CeAhR LBD and M cherry, 
nearly no bands expressing CeAhR LBD were detected. Unfortunately transgenic 
CeAhR animals were not suitable for the production of soluble CeAhR LBD for 
crystal structure study. 
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Figure 24. Agarose gel showing amplified CeAhR LBD from pPD30.38 constructs by PCR 
reaction. –ve indicates the negative control sample containing the PCR master mix and the 
primers, but without DNA to exclude contamination. Samples 1, 2, 3, 4 are four PCR 
SURGXFWVRI&H$K5/%'ZLWKQHZUHVWULFWLRQVLWHV;EDǿDQG6DFǿZLWKGLIIHUHQW70RIWKH
reaction of 54, 56, 58 or 60°C respectively. 
To show that transgenic CeAhR animals are not suitable for CeAhR LBD 
expression, DNA amplification was performed to confirm the presence of CeAhR 
LBD constructs inside the transgenic animal. This step was important to avoid bias 
in the results of the expression system. The samples in Figure 24 show successful 
integration of CeAhR LBD DNA into the genome of transgenic C. elegans strains.  
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Figure 25. 1% agarose gel carrying PCR products of amplified GST pPD30.38 construct 
integrated in the genome of transgenic C. elegans after microinjection. –ve represents the 
negative control sample for the PCR reaction containing no DNA. Samples 2 and 3 are DNA 
extracted from GST-expressing transgenic C. elegans. Samples 1 and 4 are GST pPD30.38 
with different TM. 
 
The experiment illustrated in Figure 25 was performed to confirm the integration 
of pPD30.38 constructs into the C. elegans’ genome so as to avoid false negative 
results. The DNA was amplified by Taq polymerase that was used to amplify the 
CeAhR LBD.  
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Figure 26. 1% agarose gel carrying  DNA marker on the left. The negative (–ve) control was a 
sample carrying no DNA. Sample 1 carried histidine tagged CeAhR LBD construct 
microinjected in C. elegans. Sample 2 carried GST tagged CeAhR LBD construct 
microinjected in C. elegans. All samples were amplified PCR products of the mentioned 
constructs. 
 
Another confirmatory step of successful microinjection of CeAhR LBD into C. 
elegans was performed. The difference was the new primers used to amplify the 
whole CeAhR LBD construct, not just part of it, to add more data about successful 
integration of the constructs inside the transgenic animals’ genome. The gel 
(Figure 26) shows DNA marker on the left. Hist AhR represents the sample 
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carrying amplified DNA from His tagged CeAhR LBD, while GST AhR is the 
GST tagged CeAhR LBD. The CeAhR LBD has two tags, His tag and GST tag, 
generating fragment sizes of 600 and 1.5 kb respectively. The sizes of these 
fragments were equal to the two fragments seen in the gel, suggesting successful 
integration of both tagged AhR constructs into the genomic DNA of C. elegans. 
The experiment was done to avoid false negative results. The transgenic animals 
may mutate and lose the pPD30.38 integrated plasmid carrying the target 
construct. The expression of CeAhR LBD protein was not abundant enough. It is 
important to check the genomic DNA for successful integration of the target 
recombinant DNA to avoid bias. From the above gel, it can be said that the cloning 
process was successful, however, the expression system (C. elegans) was not 
capable of expressing a large amount of recombinant CeAhR LBD in the muscle 
wall using the UNC 54 promoter.  
 
3.9 Expression of CeAhR in yeast system 
The third system of expression was Pichia pastoris GS 115 Mut+. Figure 27 
simplifies the 4 recombinant proteins expected to be expressed in this system. 
pPICZ alpha B contains alpha factor that helps secretion of CeAhR LBD protein, 
either with His tag or GST tag. On the other hand, pPICZ B constructs are 
expected to express CeAhR LBD in the intracellular compartment. C-myc is an 
epitope expressed by pPICZ alpha B and pPICZ B. The Pichia system has many 
advantages over bacterial ones. It is eukaryotic system that has post translational 
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modification capacity. Also, it is possible to express a large biomass in small 
volumes of liquid media.   
  
Alpha factor
Alpha factor
AhR
AhR
C-myc Histidine tag
AhR C-myc Histidine tag
GST
GST AhR
CeAhR in pPICZ alpha B
GST-CeAhR in pPICZ alpha B
CeAhR in pPICZ B
GST-CeAhR in pPICZ B
 
Figure 27. Four different CeAhR LBD proteins generated by the 4 plasmid constructs 
transformed in Pichia pastoris. 
 
3.10 Cloning of CeAhR LBD  
Experiments were carried out to clone PCR-amplified CeAhR LBD, or cut CeAhR 
LBD fragments, from Prset or PET41b plasmids. The PCR-amplified CeAhR LBD 
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with EcoR1 and Xba1 sites was cloned into the plasmid pGEMT. The new 
construct was transformed into JM109. To evaluate the transformation success, the 
transformed cells were plated on LB agar/ampicillin/IPTG/Blue-Gal plates. The 
resistance to ampicillin was expected to select the plasmid containing the plasmid 
pGEMT. There were no colonies in the negative control, as JM109 without 
plasmids cannot grow on ampicillin. The positive controls contain plasmids with 
an antibiotic-resistant gene. A known amount of antibiotic resistant gene acted as a 
transformation control. Each 1µg of DNA should yield 1x108 colonies. In theory, 
all positive controls or sample controls should produce colonies that are white in 
colour. The white colonies indicate successful integration of the recombinant gene 
in the plasmid (pGEMT). The results of cloning of CeAhR LBD in pGEMT 
plasmid are summarized in Table 6. It can be noticed the more insert /vector ratio, 
the more successful cloning results detected.  
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Table 6. Colony growth outcomes from transformation of JM109 with CeAhR LBD. The 
negative control had no plasmid added, the control insert is a positive control with ligated 
control insert transformed into JM109 cells via ampicillin-resistant plasmid, and background 
control was re-ligated with double digested vector (adding ligase to the double digested DNA). 
The standard reaction is the ligation reaction with DNA (CeAhR LBD constructs) 
transformed into JM109 by ligation into pGEMT plasmid. 
Plate type  Number of colonies 
Negative control 0  
Control insert 220 (60% white) 
Background control 20  
Standard reaction 
Plate1 - insert:vector ratio 1:1 
Plate2 - insert:vector ratio 3:1 
Plate3 - insert:vector ratio 10:1 
 
35 
100 
200 
 
After successful transformation, the CeAhR LBD pGEMT construct was double 
digested by Ecor1 and Xba1 restriction digestion enzymes, and run on 1% agarose 
gel. The DNA lane showed two bands, the larger one was about 3000 bp and the 
smaller about 600 bp, which was supposed to be CeAhR LBD. For the AhR GST 
pGEMT construct, the smaller fragment was 1500 bp (Data not shown). The 
CeAhR LBD band was gel purified and both pPICZ B and pPICZ alpha B were 
GRXEOHGLJHVWHGZLWKERWK(FRUǿDQG;EDǿ7KHYHFWRUV&H$K5/%'DQG&H$K5
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LBD-GST were ligated using the same method applied before for sub-cloning 
CeAhR LBD in pGEMT. The results are given in Table 7. 
 
Table 7 shows transformation of CeAhR LBD into pPICZ alphaB. The CeAhR LBD was 
double digested from pGEM7 YHFWRU ZLWK (FR5ǿ DQG ;EDǿ DQG FORQHG LQ S3,&= DOSKD %
insert that was opened with same restriction digestion enzymes. 
 
Plate type Number of colonies 
Transformation control 100 ĺ WUDQVIRUPDWLRQ HIILFLHQF\ ZDV [ 8 per µg 
DNA 
Background control 25  
Negative control 0  
Standard reaction 250  
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Table 8&H$K5/%'ZLWK%DP+ǿUHVWULFWLRQGLJHVWLRQVLWH 
GGATCCTGGATTTTTGAGAATTGACATGCGCGGAAAGTTGATGTCTCT
ACATGGATTACCATCATCGTATGTAATGGGAAGAACTGCCTCGGGTCC
AGTGCTCGGAATGATTTGCGTTTGCACACCTTTTGTGCCGCCTTCAAC
ATCCGATTTAGCATCCGAAGACATGATTTTGAAAACAAAACATCAGTT
GGATGGAGCTTTAGTATCTATGGATCAAAAGGTTTATGAAATGTTAGA
AATTGATGAAACTGATCTACCAATGCCACTCTATAATCTAGTCCACGT
GGAAGATGCAGTCTGCATGGCTGAAGCTCATAAAGAAGCTATCAAAA
ACGGGTCATCTGGTCTTCTGGTATATCGTCTAGTCAGCACAAAAACTC
GTCGTACGTATTTTGTTCAAAGCTCCTGTAGGATGTTTTACAAGAATA
GCAAACCGGAATCAATTGGCTTAACTCACAGATTACTCAACGAAGTG
GAAGGTACAATGCTTTTAGAAAAAAGAAGCACATTGAAAGCTAAACT
ATTATCATTTGACGATTCATTTCTTCAATCTCCACGAAATCTCCAATCA
ACAGCTGCACTTCCATTATAAGGATCC 
  
The CeAhR LBD ZLWK ERWK %DP+ǿ VLWHV was used for its expression in pRSET 
vector. The plasmid adds a polyhistidine tag to the CeAhR LBD protein to aid the 
purification process. 
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Table 9 &H$K5/%'ZLWK(FR5ǿDQG;EDǿVLWHV 
GAATTCACATGGGATTTTTGAGAATTGACATGCGCGGAAAGTTGATG 
TCTCTACATGGATTACCATCATCGTATGTAATGGGAAGAACTGCCTCG 
GGTCCAGTGCTCGGAATGATTTGCGTTTGCACACCTTTTGTGCCGCC 
TTCAACATCCGATTTAGCATCCGAAGACATGATTTTGAAAACAAAAC 
ATCAGTTGGATGGAGCTTTAGTATCTATGGATCAAAAGGTTTATGAAA 
TGTTAGAAATTGATGAAACTGATCTACCAATGCCACTCTATAATCTAG 
TCCACGTGGAAGATGCAGTCTGCATGGCTGAAGCTCATAAAGAAGC 
TATCAAAAACGGGTCATCTGGTCTTCTGGTATATCGTCTAGTCAGCAC 
AAAAACTCGTCGTACGTATTTTGTTCAAAGCTCCTGTAGGATGTTTTA 
CAAGAATAGCAAACCGGAATCAATTGGCTTAACTCACAGATTACTCAA 
CGAAGTGGAAGGTACAATGCTTTTAGAAAAAAGAAGCACATTGAAAG 
CTAAACTATTATCATTTGACGATTCATTTCTTCAATCTCCACGAAATCTC 
CAATCAACAGCTGCACTTCCATTATTTCTAGA 
 
For expression of CeAhR LBD in Pichia pastoris, the CeAhR were amplified by 
PCR with the new restriction digestion sites, (FRUǿDQG;EDǿ, as shown in Table 9, 
to suit cloning in pPICZ B and pPICZ alpha B vectors. 
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Figure 28. 1% agarose gel carrying CeAhR LBD GST construct in pPICZ alpha B. M is DNA 
marker. Uncut indicates the control using uncut CeAhR LBD GST in pPICZ alpha B. AhR2 
is the double GLJHVWHG&H$K5/%'ZLWK(FRUǿDQG;EDǿ7KHNEEDQG LQ$K5 ODQH LV
suspected to be the GST-tagged CeAhR LBD fragment. AhR1 is AhR GST supposed band cut 
ZLWK%DP+ǿ  WKDWJDYHEDQGV WKHPLGGOHRQH LV VXSSRVHG WREH$K5EDQG LQ$K5 ODQH
(1100kb). 
 
After successful cloning and transformation, the colonies were picked up and 
mini-prepped to extract clean plasmid DNA that is digested with suitable 
restriction digestion enzymes. Agarose gel was run and the size of the expected 
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CeAhR LBD was detected indicating the right cloning (for example Figures 28, 29 
and 30). The final step was to sequence the plasmid and make sure no errors 
happened in the construct especially in the place where the construct starts to bind 
the new vector. This strategy was applied to all 4 constructs before attempting 
expression. 
1 2 3 4
 
Figure 29. 1% agarose gel of His tagged CeAhR LBD construct in pPICZ B. It is double 
digested with Ecor1 and Xba1. The cut fragment showed the expected 600 bp in (S3,S4) of 
His-tagged CeAhR LBD cloned in pPICZ B in samples 3 and 4. The uncut samples were used 
as control in samples 1 and 2.  
 
The CeAhR LBD fragments were cut with Ecor1 and Xb1 restriction digestion 
enzymes (Figure 29). 600 bp fragments can be seen in samples 3 and 4. These two 
fragments are supposed to be CeAhR LBD. The plasmid construct was confirmed 
by sequencing. 
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Figure 30. 1% agarose gel carrying M which is DNA marker. B is pGEMT without AhR 
constructs. C is uncut pGEMT construct. A is pGEMT carrying His tagged CeAhR LBD. 
 
The CeAhR LBD fragments were cut with Ecor1 and Xba1 restriction digestion 
enzymes (Figure 30) as previously (Figure 29). 600 bp fragments can be seen in 
lanes labelled A. These two fragments are supposed to be CeAhR LBD. The 
plasmid construct was confirmed by sequencing. 
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Positive control
Negative control
 
 
Figure 31. Nitrocellulose membrane showing dot blotting of positive control His tag 
containing protein in the upper membrane strip with serial dilution of protein concentration, 
and negative sample in the lower nitro cellulose membrane strip. The negative control sample 
included bacterial and yeast extract proteins. 
 
To screen for the best colony expressing CeAhR LBD, 100 colonies were 
examined by dot blotting against the histidine and GST tags of expected expressed 
CeAhR LBD. The antibodies were subjected to test the specificity and the 
sensitivity against bacterial and yeast protein before starting the blotting 
experiment. A dot blotting experiment was done to evaluate the specificity and the 
sensitivity of the Anti His tag antibodies (Figure 31). The results showed that the 
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antibodies were sensitive to bacterial or yeast extract proteins. It is sensitive to ng 
protein concentrations. 
 
Figure 32. Dot blotting of secreted protein from a His-tagged CeAhR LBD transformed 
colony on the right nitrocellulose strip. Control nitrocellulose membrane carrying both 
positive and a negative controls are on either ends of the left strip. The strip was incubated 
with anti His antibodies. The ECL kit (western blot labiling kit) was added. The membrane 
was photographed by the BIO-RAD gel doc machine. 
 
A dot blot experiment showed that one transformed colony was positive with His-
tag antibodies (Figure 32). This promising result is not enough because dot blot is 
Ahmed Helaly                                                                                                Results                                                                                                  
 
121 
 
just a screening method. It is supposed to screen 100 transformed CeAhR LBD 
secreting colonies to detect the best one that could be reliable for large scale 
expression. The following step was to confirm the results with western blotting 
that indicate the most reliable results. 
 
 
Figure 33. Screening of different dot blotted CeAhR LBD with His tag. 1ml secretions of 100 
colonies were blotted on nitrocellulose membrane and incubated with anti His tag antibodies. 
ECL kit (western blot labeling kit) was added and the membranes were photographed by the 
gel doc machine. All results were negative except one colony, No. 71. The left plate is the 
control plate. The right plate contains 24 dotted samples. 
 
The dot blot screening of CeAhR LBD secreting colonies with His-tag showed that 
no colony managed to secrete the protein except one potential one which was 
colony No. 71. 
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Figure 34. Screening of different dot blotted CeAhR LBD with GST tag. 1ml secretions of 100 
colonies were blotted on nitrocellulose membrane and were incubated with anti GST tag 
antibodies. ECL kit was added and the membranes were photographed by the gel doc 
machine. All results were negative. The samples on the left are positive control samples. 
 
The screening of GST-AhR secreting colonies showed that no colony could secret 
any CeAhR LBD protein. From both Figures 33 and 34 it was supposed that 
CeAhR LBD was poorly or not secreted from Pichia pastoris transformed 
colonies. After screening 200 colonies, only one colony gave a potentially positive 
result. The samples could be tested by staining a gel with SYPRO RUBI that could 
detect down to 1ng protein, as in Figures 35, 36 and 37. 
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Figure 35. Protein gel stained with SYPRO Rubi stain. S1-6 is secreted His-tagged CeAhR 
LBD expression from yeast extract.   
 
A gel of proteins extracted from His-tagged CeAhR LBD tansformed colonies 
(Figure 35; S1, S2, S3, S4, S5 and S6), showed that the yeast extract contained no 
detected CeAhR LBD protein. From this experiment, there is weak evidence that 
CeAhR LBD is secreted by the Pichia pastoris system. 
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Figure 36. Protein gel stained with Commassie. C is control Pichia (without any constructs) 
protein extract after cell lysis, Hist1 is His-tagged CeAhR LBD secreting Pichia, Hist2 is 
intracellular expressing His-tagged CeAhR LBD Pichia, GST is intracellular GST CeAhR 
LBD expressing Pichia. 
 
 
Figure 37. Western blot of proteins extracted from Pichia. M is marker protein. C is Pichia 
extracted proteins without any constructs as negative control. S1,2 are secreted His-tagged 
CeAhR LBD samples. S3,4 are intracellular His-tagged CeAhR LBD expression samples. 
 
This experiment in Figure 37 indicated that the Pichia pastoris expression system 
failed to manufacture CeAhR LBD, neither secreting it nor producing it 
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intracellularly. The western blot outcome for GST CeAhR LBD was the same. 
Therefore, Pichia pastoris is not a suitable system to produce CeAhR LBD. The 
positive transformed colony from the screening was streaked onto a fresh plate and 
a new colony was picked up and grown and proteins secreted in the media were 
western blotted to detect any CeAhR LBD protein in S1 sample. Another fresh 
colony was transformed and the suspected CeAhR LBD was blotted to confirm if 
any protein can be detected. At the same time CeAhR LBD transformed colonies 
were grown and a trial to express CeAhR LBD in the intra cellular compartment 
was attempted. The cells were lysed and the desired protein was detected by a 
western blot of two samples from different colonies. The western blot was totally 
negative to dectect either secreted or internal CeAhR LBD. So it could be said that 
Pichia pastoris was not suitable for CeAhR LBD expression.   
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Figure 38. 1% agarose gel of amplified genomic DNA from Pichia pastoris carrying His-
tagged CeAhR LBD in pPICZ alpha B control (S1), His-tagged CeAhR LBD from pPICZ B 
construct extracted from genomic DNA (S2 and S3), GST-tagged CeAhR LBD in pPICZ 
alpha B control (S5) or GST-tagged CeAhR LBD in pPICZ alpha B extracted from genomic 
DNA (S6). The PCR product bands were amplified by AOX1 primers.  
 
The expression of CeAhR LBD resulted into poor out come. As applied in 
transgenic C. elegans the genomic DNA was amplified to make sure that the 
CeAhR LBD constructs were integrated in the genome of the yeast. This 
experiment shown in Figure 38 indicates successful integration of CeAhR LBD 
constructs in the Pichia pastoris genome. The genomic DNA was extracted from 
the transformed yeast samples. The control samples were pure plasmids carrying 
the constructs. Successful integration of the construct in the genome was 
confirmed by amplified DNA by PCR reaction from both the control and the 
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genomic DNA giving two equal bands amplified from both genomic and pure 
plasmid template DNA.  
 
 
Figure 39. 1% agarose gel with 1% SDS-PAGE. The samples marked M have DNA marker. 
The Yeast RNA sample was total RNA purified from CeAhR LBD expressing yeast. Control 
indicates already intact purified rat total RNA extracted from the liver. 
 
An experiment was then conducted to check that the extracted RNA was intact and 
ready for reverse transcriptase PCR (see below). The RNA sample was not 
smeared indicating little or no degradation of the yeast RNA. The samples in 
Figure 39 showed intact total RNA extracted from Pichia pastoris expressing His-
tagged CeAhR LBD. There was no smearing, and the amount of RNA was 
abundant.  
Ahmed Helaly                                                                                                Results                                                                                                  
 
128 
 
 
 
Figure 40. Reverse transcriptase (RT) PCR of CeAhR LBD cDNA. The figure shows 1% 
agarose gel for RT PCR of cDNA made from total RNA extracted from Pichia pastoris. The 
samples consist of DNA marker in the extreme left (KB+). R1,R2 are amplified DNA by PCR 
from cDNA made from yeast extracted total RNA. –ve control sample is RNA amplified by 
PCR to evaluate genomic contamination. +ve control samples are template CeAhR LBD 
construct in pPICZ B. These DNA samples were amplified with specific CeAhR LBD primers. 
C is PCR (using AOX 1 primers) of Pichia pastoris CS 115 transformed with pPICZ B, which 
confirms the presence of endogenous alcohol oxidase, that is to say that this is Pichia pastoris 
Mut+ strain. 
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The experiment illustrated in Figure 40 indicates the presence of the RNA 
transcript from the CeAhR LBD gene integrated in the genome of Pichia pastoris.  
 
3.11 Effects of AhR agonists on the viability of C. elegans 
Six compounds were tested for their effects on C. elegans, namely TCDD, AZ1c, 
PCB126, AMB 0& DQG ȕ-naphthoflavone. 1 M sodium azide was used as 
positive control and 1 mM DMSO as vehicle control. C. elegans N2 animals 
without any toxin were used as a negative control. The results showed that sodium 
azide killed all animals, indicating a successful positive control. No animal 
pathology was detected in both negative and vehicle controls. Regarding AhR 
agonist compounds, no gross pathology was detected with PCB126, 3MC, AMB or 
ȕ-naphthoflavone. While both AZ1c and TCDD could not kill any C. elegans, both 
chemicals managed to limit the movement of L4 animals at the highest 
concentration tested (1 nM for AZ1c and 1 µM for TCDD). It was clear that the 
movement of L4 C. elegans was sluggish in contrast to the negative control 
animals. On repeating the lethality test of both TCDD and AZ1c on AhR null C. 
elegans (CZ 24 85), the effects of both TCDD and AZ were abolished; the animals 
were moving freely and there was no difference from the negative control animals. 
This indicates that the C. elegans response to TCDD and AZ1c was mediated by 
CeAhR. 
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Figure 41 The effect of increased concentration of AZ1c in nM on the movement of wild type 
C. elegans. The movement of the animals was affected by only the highest soluble 
concentration of compound. The data points are means from three repeats. The curve fit is a 
four-parameter logistic equation giving an estimated IC50 of 0.59 nM. 
 
3.12 Induction of CYP-GFP fused transgenic C. elegans 
Strains of transgenic (CYP-GFP fused) animals (CYP35A2, CYP29A2 and 
CYP34A9) were subjected to induction by different known AhR agonists. This 
experiment aims to see if CeAhR can induce any CYP family genes as a model  
for humans. These 3 CYP enzymes are known to deal with xenobiotic responses in 
C. elegans. It is thought that one of them could correspond to human CYP1A1 and 
it could be induced by AhR agonists in C. elegans. The fluorescence (total) of 
these animals was measured by the dark reader machine aiming to detect the 
corresponding CYP enzyme induced by AhR (see Table 10). None of the 
fluorescence readings in the presence of the test compounds increased above that 
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of the control samples in their absence. This indicates that none of the CYP 
enzymes were induced by any of the compounds. 
Table 10. Fluorescence of CYP-GFP fused transgenic C. elegans induced by serial dilutions of 
TCDD, AZ1c, 3MC, PCB126 and AMB). The C. elegans were exposed to the compounds for 3 
days before measuring the amount of fluorescence. 
Compound Concentration Fluorescence due to CYP induction 
CYP35A2 CYP29A2 CYP34A9 
TCDD 
control 259 270 259 
0.001 µM 230 214 228 
0.01 µM 240 276 266 
0.1 µM 224 243 235 
1 µM 219 243 271 
AZ1c 
control 288 277 294 
0.001 nM 262 254 270 
0.01 nM 269 271 255 
0.1 nM 266 249 261 
1 nM 270 281 288 
3MC 
control 277 277 291 
0.02 µM 266 259 278 
0.2 µM 271 269 277 
2 µM 265 281 279 
20 µM 279 277 284 
PCB126 
control 288 299 291 
0.01 µM 265 277 270 
0.1 µM 268 270 268 
1 µM 271 271 269 
10 µM 259 288 288 
AMB 
control 269 259 278 
0.1 nM 270 270 266 
1 nM 268 281 276 
10 nM 259 271 269 
100 nM 294 277 280 
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4 DISCUSSION 
 
AhR is a cytosolic receptor that binds multiple ligands (Zhou et al., 2010) and has 
a xenobiotic function in the metabolism of various toxic substances (Wang et al., 
2009). AhR is also a target of many drugs like omeprazole and tamoxifen 
(Yoshinari et al., 2008; DuSell et al., 2010). AhR mediates the toxic effects of 
many pollutants including one of its most notable agonists, 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD). TCDD is considered the full agonist of 
human AhR (Howard et al., 2010). Its stimulation induces non-genotoxic 
carcinogenesis (Cole et al., 2003; Schwarz and Appel 2005; Ellinger-Ziegelbauer 
et al., 2009). AhR stimulation creates a model for cancer in humans, and so 
understanding how AhR works becomes very important. Crystal structure studies 
on mouse and human AhR, and especially its ligand binding domain, resulted in 
poor outcomes (Lo Piparo et al., 2006). The 3-dimensional structure of AhR is 
important to understand how this receptor binds different structures and chemicals 
with different affinities, either agonists or antagonists. Despite the diversity 
between these ligands, it is not known how AhR binds to all these chemicals. 
Furthermore, AhR is considered as an orphan receptor, without a known 
endogenous ligand (Kung et al., 2009). The 3-dimensional structure of CeAhR is 
proposed to be a good template for creating a computer-based human AhR model. 
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This theory is attributed to the structural similarity between the ligand-binding 
domains of both proteins. The CeAhR LBD has the closest structure to the 
mammalian AhR compared to other non-mammalian species; the yielding protein 
domain shares nearly 50% similarity with human AhR LBD. It is suggested that 
expression, purification and crystallization of CeAhR would be easier than 
mammalian AhR, as it is thought to require less complex chaperones to fold, and it 
is expected to be an alternative to mammalian AhR crystal structure study. CeAhR 
is not known to bind ligands, but then its LBD is supposed to be less complex in 
structure, requiring less difficulty to be expressed in a soluble folded form. As a 
result, it is possible to obtain a human AhR model that is more compatible with the 
real 3-dimensional structure of AhR. 
Furthermore, there is another debate about the function of CeAhR, whether it is a 
receptor or a transcription factor without a ligand pocket at all. Powell-Coffman 
and her group characterised AhR-1 in 1998, and tested its functionality by co-
immunoprecipitation with rabbit HSP90, and confirmed that AhR-1 does not bind 
TCDD in vitro. The theory that AhR-1 LBD does not have a ligand-binding pocket 
makes its expression easier than human AhR. It is supposed that the AhR pocket 
collapsed during recombinant expression of mammalian receptors making 
crystallization difficult. Comparison between CeAhR and human AhR LBD 
revealed nearly 50% similarity; therefore, it is logical to use AhR-1 LBD domain 
as a template for human AhR with more accuracy than previous models proposed 
(Pandini et al., 2007; Pandini et al., 2009; Jogalekar et al., 2010). They used bHLH 
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templates with less than 30% similarity. The idea that CeAhR had no ligand-
binding pocket and better similarity coupled to the probability of better expression 
generated hope of achieving a better human AhR model by attempting expression 
of CeAhR LBD. 
The study showed that attempts to express CeAhR LBD in 3 different expression 
systems did not produce any significant quantities of purified soluble protein and 
far less than would be required for crystallization studies. The worst result was in 
the Pichia pastoris expression system, which expressed no protein at all. The 
results of expression of CeAhR LBD in the body muscle wall of transgenic C. 
elegans were very poor. The best expression system determined by this study was 
also the simplest, namely E. coli. The study expressed CeAhR LBD in both 
PL21(DE3) cells and Arctic express DE3 cells. The outcome of soluble CeAhR 
LBD was better with lower temperature expression in Arctic express cells. The 
problem was that the amount of soluble CeAhR LBD was too little. To get 1 mg of 
soluble CeAhR LBD, provided there was no loss during purification, would 
require 10 to 20 litres of bacterial culture. The study moved to answer the 
question, why CeAhR LBD expression was more difficult than expected. 
Experimental work was performed in Pichia pastoris but although it was possible 
to detect the RNA of the recombinant CeAhR LBD gene indicating successful 
transcription of CeAhR LBD inside the Pichia cells, no protein was produced.  
Studies of the effect of known AhR ligands on both wild type C. elegans and AhR 
null live animals showed that CeAhR can no longer be considered a non-
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xenobiotic binding domain. CeAhR responded to TCDD and AZ1c in the in vivo 
study. The study further tried to detect if CeAhR induced any of GFP.CYP35A2, 
GFP.CYP29A2 or GFP.CYP34A9 genes. These CYP genes are known to be 
induced in response to xenobiotic effects (Menzel et al., 2001). However, none of 
these genes were induced by TCDD or the other chemicals applied in this study. 
AhR and ARNT genes in C. elegans were discovered by Powell-Coffman and her 
group in 1998. They discovered a DNA sequence coding for a protein that has 
structural similarity to the PAS domain of mammalian AhR. The group amplified 
this DNA segment that is obtained from a mixed-stage cDNA library, and named 
the gene AhR-1 (aryl hydrocarbon receptor-related). Fortunately, AhR-1 protein 
(CeAhR herein) shares 38% identity with human AhR over a region of 395 amino 
acids; furthermore, alignment showed that CeAhR is closely related to mammalian 
AhR in the PAS domains. What makes CeAhR more interesting is that it has 
similar biochemical properties to mammalian AhR (Bell and Poland 2000). 
CeAhR contains both bHLH and PAS domains like vertebrate AhR. Studies 
showed that this protein contains a PAS-B domain, which is the ligand-binding 
domain in mammalian AhR. On the other hand, the PAS-A domain of CeAhR 
shows ~56% amino acid identity with the corresponding sequence of mammalian 
AhRs. The bHLH sequence is less similar to the bHLH sequence in vertebrate 
AhRs. These observations suggest that CeAhR protein is a good model for 
mammalian AhR, as it has similar structural and biochemical properties (Hahn et 
al., 1997).  
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SDS-PAGE analysis of protein from His-tagged CeAhR LBD transformed 
BL21DE21(DE3) cells showed the expressed protein band at about 29 kDa, which 
would be expected for his-tagged CeAhR LBD and was the only difference from 
the antisense control. This experiment strongly implies expression of CeAhR 
LBD. Studies have been performed to express mammalian AhR in a baculovirus 
system and their outcome was also successful induction of AhR, yet the major 
obstacle was the fact that most of the expressed protein was insoluble (Chan et al., 
1994).  
The E. coli cells were sonicated to separate the soluble protein content, and also 
centrifuged at 10,000ug to remove the insoluble protein. The soluble component 
was further centrifuged at 250,000ug. The protein bands were compared to the 
pelleted Prset transformed BL21(DE3) cells. Protein sequencing of soluble 
fractions confirmed that the CeAhR LBD protein was induced and present. CeAhR 
LBD was also transformed into Arctic Express Cells. Both BL21(DE3) and Arctic 
Express DE3 cells use the strong T7 promoter. However, Arctic Express cells 
expressed more soluble CeAhR LBD at lower temperature (12°C). The problem of 
recombinant expression in E. coli is too fast production of a large amount of 
recombinant protein that accumulates in the inactive form of inclusion bodies. 
These require a lot of effort to refold, and even if successful, it is difficult to 
guarantee that the refolded CeAhR LBD protein is biologically active to study its 
structure. Arctic Express cells grow at low temperature giving good opportunity to 
express soluble AhR. Furthermore, Arctic Express cells have been modified to 
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express chaperones cpn10 and cpn60. These chaperones could stabilize the 
recombinant protein tertiary structure and express more functional protein. Indeed, 
Arctic Express results were better than PL21(DE3), but the overall soluble protein 
expression was still poor.   
 
4.1 Solubility of the protein  
SDS-PAGE analysis of soluble His-tagged CeAhR LBD, after purification within a 
nickel column, was performed. The results of the column protein bands were 
compared with serial dilution of BSA to evaluate the amount of purified protein. 
Unfortunately, the amount of the protein was too little, and seen only in the wash 
samples of the column. No protein was detected in the eluted samples. Even 
though soluble protein could be obtained from the bacterial expression system 
without complex chaperone protein, the amount of soluble protein is small. It 
would take more than a 10 litre culture of E. coli to purify less than 1mg of soluble 
His-tagged CeAhR LBD. For large-scale culture, purified CeAhR LBD 
expression, we would need tens of litres or more of E. coli culture. Studies showed 
that high throughput (HTP) expression of C. elegans proteins in E. coli processed 
10,167 different C. elegans genes. 4854 (47.7%) proteins were successfully 
expressed, and of these, 1536 (15.1%) were soluble proteins. Only 590 proteins 
were expressed at a large enough scale for crystal structure studies (Finley, 2004). 
Cytoplasmic proteins are less easily secreted than membrane proteins, and 
homomeric proteins are less soluble too. The presence of a large number of 
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cysteine amino acids is a bad indicator of protein solubility (Luan et al., 2004). 
CeAhR LBD has few cystiene residues which is a good sign, however most of the 
expressed CeAhR LBD in bacteria was insoluble; it is noteworthy that AhR is a 
cytosolic protein. 
 
4.2 GST and poly histidine tag fusion proteins 
The study indicated that CeAhR LBD should be fused with GST and poly histidine 
tags. The major aim of both tags was to make the purification of CeAhR LBD 
simpler. It is worthy to compare both tags regarding expression. Also, the 
comparison between the 2 different proteins’ crystal structure will support the 
credibility of AhR structure analysis; in other words, consistent AhR crystal 
structure, despite different fusion tags, indicates robust AhR folding. On the other 
hand, the fusion protein tags interfere with the biochemical study of the expressed 
protein. The presence of the fusion tag protein at the start of translation of the 
protein may express less recombinant protein as the first amino acid sequence is 
important in protein signalling. The presence of the tag protein at the end of the 
target protein may be a better option to improve the expression of the protein. 
 
4.3 AhR Expression in Pichia pastoris 
The yeast expression system has many advantages that make it a good choice for 
CeAhR LBD expression on a large scale. Pichia pastoris is a eukaryotic system 
that can carry out post-translational modifications by virtue of its endoplasmic 
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reticulum. So the soluble, expressed protein secreted by that system is supposed to 
be functional. This is a very important advantage, because CeAhR is not known to 
have a specific ligand with which to assess its functional capabilities. A major 
question arises here: how would CeAhR LBD be assessed in a functional way? 
First, it would be soluble, second, it would not be aggregated, and third, if it could 
be crystallized and its structure solved, it will be fairly obvious if it is a PAS 
protein fold or not. Finally, successful CeAhR LBD secretion by the yeast 
expression system will indicate functional post-translational modification. The 
Pichia pastoris system is supposed to have more complex chaperones that could 
help in expressing more soluble CeAhR LBD. Other advantages offered by the 
yeast expression system include: 1. Yeast yields a high level recombinant protein 
due to the presence of a large copy number of vectors per cell. 2. The promoter is 
strong and stable. 3. The system is characterised by high cell density. 4. The yeast 
system can produce dry-cell weight densities that exceed 100 gram/litre. 5. Yeast 
requires growing media which is simple and inexpensive. 6. As yeast is eukaryotic, 
it is capable of expressing soluble, complex mammalian proteins. 7. Recombinant 
plasmids are integrated in the chromosomal DNA of the yeast genome making the 
recombinant DNA stable for different generations. 8. Yeast expression is durable, 
and requires no complex care. It is, therefore, usually very suitable for generating a 
large amount of functional protein for 3-dimensional structure studies.  
In this study expression was mediated by the AOX1 promoter (Cereghino and 
Cregg 2000; Cregg et al., 2000; Lin Cereghino et al., 2001). Dot blot screening of 
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100 colonies of His-tagged CeAhR LBD transformed Pichia were studied, but only 
one colony gave positive results. The whole 100 colonies of GST CeAhR LBD 
gave no signal at all. It seems that achieving CeAhR LBD expression in Pichia 
pastoris is a difficult task. It is important to say that dot blot screening may yield 
false positive results and it is essential to further analyse the Pichia colonies by 
western blot. The dot blotting screened the possible secreted CeAhR LBD in the 
surrounding media. The cornerstone of success in that expression system is the 
ability to secrete CeAhR LBD protein even in minute amounts. Secreted protein 
should be subjected to post-translational modification, and supposed to be a 
functional and good candidate for crystal structure work. The western blot results 
concluded that the expression of CeAhR LBD was very poor, both secreted and 
accumulated intracellularly. The unfortunate results of the secreted pPICZ alpha B 
may be explained by the theory that CeAhR LBD is a cytosolic protein and tends 
to stay intracellular. It was hoped that Pichia could secrete even nanogrammes of 
CeAhR LBD protein, and later on the biomass is concentrated making a number of 
litres yield a few mg of protein, yet no CeAhR LBD was secreted at all. The 
positive results of the dot blot in one colony were clearly a false positive. 
Furthermore, testing for intracellular CeAhR LBD protein revealed similar poor 
results. The western blot failed to detect any CeAhR LBD expressed by Pichia 
pastoris. Despite the expectation that the yeast system might be more productive 
than the bacterial system, clearly the opposite was true. It is quite difficult to 
predict the results of expression systems in advance. 
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The first step to track protein manufacturing is checking for successful DNA 
integration into the genome of the yeast. The genomic DNA of the recombinant 
yeast was extracted and amplified by PCR reaction targeting the recombinant 
DNA. It showed that the DNA of CeAhR LBD was successfully integrated.  
The total RNA was extracted from Pichia pastoris transformed by CeAhR LBD 
constructs. The RNA was reverse transcribed to cDNA which was amplified by 
PCR reaction and the PCR product showed the CeAhR LBD gene in agarose gel. 
This showed that there was no problem with transcription of CeAhR LBD inside 
Pichia pastoris. Therefore, the problem may be in the translation process or after 
translation. After translation the recombinant protein is subjected to post-
translation modification in the eukryotic system which is supposed to result in 
folded protein.  
The process of recombinant protein expression could be intrupted at any of these 
stages. On the other hand all the above process may be successful and the protein 
may be subjected to degradation. It is important to remember that the pH and 
redox state may affect the production of recombinant proteins in different 
expression systems favouring one protein over another. In this case the problem 
occurred downstream of mRNA transcription but to precisely determine which 
further step failed would be a major undertaking. 
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4.4  AhR Expression in transgenic C. elegans  
The third trial was to try and express CeAhR LBD in transgenic C. elegans itself. 
The CeAhR LBD is supposed to be expressed with both GST and His tags in the 
muscle wall of C. elegans. The protein expression was mediated by the UNC 54 
promoter. The CeAhR LBD DNA was microinjected with M cherry marker. The 
problem was that M cherry uses the same promoter as the pPD30.38 constructs of 
CeAhR LBD. Other markers not using UNC 54 have been tried, but were toxic to 
C. elegans. The CeAhR LBD expression results were poor also. C. elegans failed 
to express CeAhR LBD in the muscle wall, although transgenic C. elegans should 
contain all the chaperones needed to manufacture its own protein or at least the full 
length CeAhR. It is important to say that the target protein is only a domain of a 
larger protein and may lack the regions necessary for interactions with chaperones. 
It may also be that this protein is considered foreign as it is expressed with foreign 
tags in the muscle wall, which is not the normal intracellular environment. 
However, PAS domain proteins have been successfully expressed independent to 
the N-terminus region. It is not known whether the expression of the full length 
CeAhR would be more successful than just the LBD.   
 
4.5 Comparison of expression systems 
So, three trials of CeAhR LBD expression were performed with disappointing 
results. The best expression system was Arctic Express cells. It is difficult to know 
why some protein expression succeeds in one system and fails in another. For 
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example, promoter strength, pH, local ionic environments, redox state, copy 
numbers, transcript levels, codon bias, chaperone levels or chaperone affinities 
may be important factors that decide the success of one system or another for a 
particular protein (Herrero and Sentandreu 1988; Gregory A Petsko 2009). The 
expression of CeAhR LBD was best at lower temperature (12 oC). 
 
4.6 C. elegans AhR endogenous function 
The endogenous function of CeAhR was studied by Qin and Powell-Coffman in 
2004. It is known that CeAhR is strongly related to the neurological maturation of 
C. elegans. Binding assays showed that TCDD was not binding to CeAhR 
expressed in vitro. It is not known if CeAhR functions as a receptor in vivo, or 
works as a transcription factor without any ligand at all. In this study an 
experiment was carried out to determine whether any known AhR ligands affect 
live C. elegans. Lethality tests were performed with 6 different known mouse AhR 
ligands from different groups on N2 C. elegans. The results showed that all 6 
compounds have no lethality effects on N2 wild type C. elegans. However, both 
TCDD and AZ1c had a behavioural effect on wild type animals. At the maximum 
soluble level, both compounds induced limitations in the movement of the animal 
in contrast with negative control C. elegans. The experiment was repeated 3 times 
with the same finding. These limited effects of ligands are attributed to the weak 
solubility of TCDD and AZ1c. However, it implies that C. elegans contains active 
AhR that binds TCDD in mice and humans. A very important question arises here. 
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Is the CeAhR LBD responsible for these new findings or is another gene with 
different receptor protein binding TCDD? It is known that Zebra fish contains 2 
AhR proteins, namely AhR1 and AhR2, and only one of them actively binds 
TCDD. In order to solve this problem, the in vivo tests were repeated with TCDD 
and AZ1c with CeAhR null animals, i.e. (CZ 85 24) strains. These strains have no 
functioning AhR-1. The results revealed completely functioning animals that are 
identical to the control, that is to say that AhR null C. elegans abolished the effect 
of TCDD and AZ1c. This indicates that the CeAhR LBD could bind ligands that 
are active at mammalian AhRs.  
The study in 1998 by Powel-Coffman indicated that CeAhR does not bind ligands. 
However, this in vivo study indicates the opposite. In Powell-Coffman’s (1998) 
study, they checked protein functionality by active binding with HSP90. It seems 
that HSP90 binds to a pocket away from the AhR LBD, and this contrasts with the 
previous data in the literature (Fukunaga et al., 1995). It assumed that CeAhR was 
fully active because, like mouse or human AhR, it bound HSP90. Recombinant 
CeAhR binds HSP90, but not TCDD (Powell-Coffman et al., 1998). However, this 
in vivo study says that CeAhR binds TCDD. This may be explained by saying that 
ligands and accessory proteins bind to two different sites on AhR. So presumably 
the protein was not functional in terms of ligand binding when it was used in the in 
vitro study but it is in vivo. From this work it can be said that protein folding in 
vivo is different from that in vitro. This result can be applied for different proteins.  
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Previous studies claimed that the PAS B domain is the place where HSP90 and the 
proposed ligand combine with the LBD (Pandini et al., 2007). It is suggested that 
this model is not accurate for C. elegans. It seems that AhR has multiple binding 
sites where chaperones and ligands bind. These results support some theories 
claiming that multiple ligands bind to multiple sites (Henry and Gasiewicz 2008). 
These models show only one cavity for ligand binding and depend on templates 
with similarity of less than 50%. Therefore, there are some doubts about the 
accuracy of these models (Lo Piparo et al., 2006; Pandini et al., 2007; Bisson et 
al., 2009; Jogalekar et al., 2010). A lack of success in crystal structure studies of 
any AhR protein makes such models ambiguous. Also, there is no data on the 
quaternary structure of AhR, whether AhR is a monomer, dimer, or multi-subunit 
protein. From the evolutionary point of view, it was thought that invertebrate AhR 
was a transitional stage before full maturation of the function in humans. However, 
this statement may not be true. CeAhR is advanced in function and binds 
xenobiotic ligands like vertebrates, and thus its structure is supposed to be as 
complex as human or mouse AhR. This may be why the expression of CeAhR was 
difficult, as it is in humans and mice. 
 
4.7 Induction of cytochrome P450 analogues in C. elegans 
Three strains of C. elegans were used to test for induction of several CYP genes. 
The strains were GFP-CYP29A2, GFP-CYP35A2 and GFP-CYP34A9. The results 
concluded that ligand bound CeAhR does not induce these 3 cytochrome P450 
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enzymes. However, there are more than 60 such enzymes in C. elegans. 
Microarray analysis on AhR-mutated L1 stage C. elegans showed that 324 genes 
were down-regulated and 238 genes were over-expressed; these genes were related 
to fatty acid metabolism, growth and development (Aarnio et al., 2010). Previous 
VWXGLHV VKRZHG WKDW ȕ-naphthoflavone has been found to induce CYP35A2 
(Menzel et al., 2001; Schafer et al., 2009). However, in the present study, 5 
different AhR agonists (TCDD, AZ1c, 3MC, PCB126, AMB) did not induce any 
of CYP35A2, CYP29A2, or CYP34A9. This may be explained by multiple 
pathways of metabolism for different chemicals in C. elegans. The AhR agonist 
chemicals used in this study are poorly soluble in water, and it may be that the 
concentration of these chemicals was not strong enough to induce CYP35A2 
grossly. On the other hand, the lethality test experiment of ȕ-naphthoflavone on 
wild type C. elegans showed resistance to the toxicity of this compound at the 
KLJKHVW VROXEOH FRQFHQWUDWLRQ ,W LV QRW NQRZQ LI ȕ-naphthoflavone is an AhR 
ligand in C. elegans, and so this drug may be metabolised in a different manner or 
it induces CYP35A2 at a low level that could not be detected by the assay used 
here. The study performed by Menzel et al. (2001) induced CYP in transgenic C. 
elegans that contain transgenic CYP35A2 in the intestine. They detected the 
induction by visualising the muscle wall florescence, but not measuring the total 
absorbance from the animal. It is not known if CeAhR induces any of the CYP 
family in C. elegans that are homologous to those in mammals. 
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4.8 Future work  
If it is possible to grow 50 litres of E. coli (Arctic Express DE3) this could yield 
about 5 mg of soluble CeAhR LBD that could be subjected to crystal structure 
study, or at least protein characterization with different protocols, for example 
analytical ultra centrfugation. 1 mg of the soluble CeAhR LBD can provide a lot 
of data about the configuration of CeAhR that could help further studies. It is 
important to say that CeAhR LBD is a part of a protein. Expression of the whole 
CeAhR protein is another project. It is not known if the expression of the whole 
protein may result in better folded AhR with better solubility. It is possible to 
conjugate CeAhR with both GST and GFP tags at the same time in a new study to 
enhance the protein’s solubility and at the same time help purification easily; the 
GFP would help protein solubility (Gonzalez-Montalban et al., 2007) and GST tag 
would help in the purification of CeAhR. It is also possible to study more CYP 
family members fused with GFP to see if any of these are induced by CeAhR 
activation. This is not easy work, because C. elegans has 60 different CYP family 
enzymes. In this case, it would be sensible to apply computer-based homology 
determinations to find the most homologous CYP enzyme in C. elegans to 
CYP1A1 in mammals. It is possible later on to fuse this CYP enzyme with GFP 
and perform an induction study on it. It is important to remember that it is not 
clear if C. elegans has a xenobiotic metabolic function as in humans, although the 
data herein implies that it does. It is possible in the future to try more compounds 
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and more types of behavioural assay, for example, brood size assay, growth assay 
and feeding assay.  
 
4.9 Conclusion 
 It can be concluded from this study that CeAhR has similar criteria to the 
mammalian AhR. It binds xenobiotic ligands as it does in mammals but perhaps 
with lower affinity. Therefore, crystal structure work of that protein is more 
relevant than previously thought. On the other hand, difficulty in expressing 
CeAhR would be expected as in other species. The success in expressing a very 
small amount of soluble CeAhR LBD in bacteria is encouraging to continue this 
work in future with larger scale facilities. Moreover, there is hope to achieve the 
target of this project in performing a crystal structure study of CeAhR either LBD 
or the full length protein. It should be emphasised that CeAhR is a receptor that 
binds ligands, and it is important to study the battery of genes affected by CeAhR. 
C. elegans could be a good model for dioxin toxicity and cancer evolvement that 
could help in understanding AhR biology. It is worthy to say that C. elegans is still 
a good model for human AhR 3-dimensional structure, despite the difficulties in 
application. 
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